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The fetal ovary exhibits temporal 
sensitivity to a ‘real-life’ mixture of 
environmental chemicals
Richard G. Lea1,*, Maria R. Amezaga2,†, Benoit Loup3, Béatrice Mandon-Pépin3, 
Agnes Stefansdottir2,‡, Panagiotis Filis2, Carol Kyle4, Zulin Zhang4, Ceri Allen1, Laura Purdie1, 
Luc Jouneau3, Corinne Cotinot3,*, Stewart M. Rhind4,*,§, Kevin D. Sinclair1,* & Paul A. Fowler2,*
The development of fetal ovarian follicles is a critical determinant of adult female reproductive 
competence. Prolonged exposure to environmental chemicals (ECs) can perturb this process with 
detrimental consequences for offspring. Here we report on the exposure of pregnant ewes to an 
environmental mixture of ECs derived from pastures fertilized with sewage sludge (biosolids): a 
common global agricultural practice. Exposure of pregnant ewes to ECs over 80 day periods during 
early, mid or late gestation reduced the proportion of healthy early stage fetal follicles comprising the 
ovarian reserve. Mid and late gestation EC exposures had the most marked effects, disturbing maternal 
and fetal liver chemical profiles, masculinising fetal anogenital distance and greatly increasing the 
number of altered fetal ovarian genes and proteins. In conclusion, differential temporal sensitivity of 
the fetus and its ovaries to EC mixtures has implications for adult ovarian function following adverse 
exposures during pregnancy.
The deleterious effects of exposure to environmental chemicals (ECs), including endocrine disrupting com-
pounds (EDCs), on female reproductive function have been demonstrated in diverse species1,2, especially at 
immature life stages3,4. However, most mechanistic studies have been performed in rodents using single chemicals 
[e.g.5], but in these species ovarian follicle assembly begins two days before birth and oocytes are only enclosed in 
follicles during the first few days after birth, unlike the human6. Therefore, we previously subjected pregnant ewes 
to a complex mixture of ECs for a prolonged period by grazing pastures fertilized with sewage sludge (biosolids); 
a common agricultural practice. This valuable fertilizer contains readily detectable levels of EDCs7–10 which, 
through release into the environment, represents animal and human exposure. Indeed, the very complexity of the 
EC mixture, which would be problematic to reproduce artificially, provides a means of investigating the effects of 
real-life maternal exposure on the fetus. We have reported that prolonged use of sewage sludge fertilizer increases 
the soil content of many ECs/EDCs11. Pertinently, approximately 8 million dry metric tonnes of sludge are pro-
duced in the USA and EU per annum. This translates to a sludge density (dry metric tonne/annum/km2) of 1.6 
in the USA and 4.6 in the EU7. Whilst ECs in pregnant ewe tissues are minimally affected by sewage sludge expo-
sure8,9, concentrations of ECs in maternal and fetal livers are generally different. Some ECs appear to be present at 
higher levels in the fetus (e.g. PCB 101) whilst others (e.g. DEHP) show accumulation in both mother and fetus9. 
Despite these observations, fetuses from ewes following prolonged exposure exhibit disturbed ovarian10,11, testic-
ular12, thyroidal13 and hypothalamo-pituitary axis14,15 development. Adult male offspring exposed both pre- and 
post-natally, exhibited perturbed testicular morphology16 and feminized behavior17.
Ovarian development in precocial mammals, including humans, extends across much of gestation. Within the 
context of environmental perturbation, identification of stages of ovarian development most influenced by ECs 
requires rigorously controlled exposure at different stages of gestation and associated measurements of: (a) tissue 
chemical burdens, (b) indices of fetal, particularly ovarian development, and (c) patterns of gene and protein 
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expression. We therefore exposed pregnant ewes, at different stages of gestation, to pastures fertilized with sewage 
sludge. Exposure occurred during three overlapping 80-day periods depicted in Fig. 1. These encompassed early 
(0–80 dpc), mid (30–110 dpc), and late (60–140 dpc) gestation. Exposures were compared to controls (inorganic 
fertilizer) and to continuous sewage sludge exposure (0–140 dpc). During days 0–80, the gonads differentiate 
(25 dpc), primordial germ cells migrate to and proliferate in the gonads (25–45 dpc), meiotic prophase I occurs 
(55–60 dpc) and primordial follicles form (75–80 dpc)18,19. Fetal hypothalamo-pituitary function develops after 
60 dpc20, and by 140 days the first antral follicles are present21, with birth at 145–150 dpc. Using this model we 
establish the gestational periods during which the fetal ovary is most sensitive to perturbation by a complex, low 
dose, mixture of ECs.
Results
Effects of sludge exposure on 31 ECs in fetal and maternal liver. Soil concentrations of ECs 
were increased by sewage sludge application, especially polycyclic aromatic hydrocarbons (PAHs): ∑ 16 PAHs 
increased from 1812 to 3162 μg/kg soil. In addition, ∑ 7 polychlorinated bisphenyl (PCB) congeners rose from 
0.11 to 0.14 μg/kg soil whereas ∑ 7 polybrominated diphenyl ethers (PBDEs) remained constant at 0.60 μg/kg soil. 
Di(2-ethylhexyl)phthalate (DEHP) also increased from 60 to 80 μg/kg soil.
In maternal livers, 10 of the 15 significant alterations in chemical concentrations were manifest by an increased 
chemical burden following exposure to sludge treated pastures (Supplementary Fig. S1). Significant differences in 
some PAH, PBDE and PCB congeners only occurred in the 30–110T and 60–140T groups. DEHP was increased 
in all 3 transient exposure groups (0–80T, 30–110T, 60–140T). Fetal liver EC concentrations at Day 140 were 
highly variable and the only significant differences from controls (0–140C) were in the 30–110T and 60–140T 
groups (Supplementary Fig. S2), with significant increases only in the 30–110T group (PBDE100, PCB52). In 
contrast, benzo(a)anthracene and specific PBDE (28,47) and PCB (28,101,118,138,153,180) congeners were 
decreased in one or both of the mid and late exposure groups. Consistent with previous studies8,22,23, measured 
fetal and maternal liver EC concentrations could not be equated with concentrations in soil e.g. PAH chemicals 
(Supplementary Table S1).
Effects of sludge exposure on maternal body condition score and fetal urogenital tract and 
endocrinology. Exposure to sewage sludge had no effect on maternal BCS (0–140C: 2.29 ± 0.04, 0–140T: 
2.21 ± 0.04, 0–80T: 2.21 ± 0.04, 30–110T: 2.19 ± 0.15, 60–140T: 2.09 ± 0.05). Day 140 female fetal mass in all 
but one (i.e. 0–140T) exposure group was lower (P < 0.001) than controls (Table 1). Normalized (for fetal mass) 
fetal anogenital distances (AGD) were greater (P < 0.05) in fetuses of the 30–110T and 60–140T exposure 
groups relative to 0–140C fetuses. Normalized fetal liver mass was reduced (P < 0.05) in the 0–140T group but 
increased (P < 0.05) in the 60–140T group. Normalized fetal thyroid and uterine mass in the 60–140T group was 
increased (P < 0.05) and reduced respectively relative to controls. Fetal hormones were altered (P < 0.05) in the 
0–80T group (testosterone increased) and in the 60–140T group (free T3 and T4 were reduced and increased 
respectively).
Effects of sludge exposure on ovarian development. Normalized fetal-ovarian mass was not affected 
in any sludge exposure group (Table 1). Overall follicular density (number/mm2) was not affected by exposure 
[All follicles: 0–140C: 17.57 ± 7.10, 0–140T: 18.42 ± 3.34, 0–80T: 18.67 ± 4.32, 30–110T: 28.03 ± 3.75, 60–140T: 
34.25 ± 6.77] and similarly, the percentage of all follicles in each follicle type in the day 140 ovaries did not alter 
across groups [Type 0: 3.3 ± 0.7%, Type 1: 20.8 ± 2.1%, Type 1a: 63.0 ± 1.3%, Type 2: 14.6 ± 2.3%, Types 3–5: 
1.7 ± 0.4%]. However, the proportion of healthy post-primordial transitory follicles (i.e. Type 1a: Fig. 2a.ii), 
representing the largest class of Day 140 fetal-ovarian follicle, was reduced (P < 0.05) in all exposure groups 
(Fig. 2b, Table 2). This corresponded with a separately-counted increase in the proportion of atretic Type 1a fol-
licles (Fig. 2a.iv,b) and an increased proportion of follicles with intense nuclear staining (Fig. 2a.v) specific to the 
0–80T and 30–110T groups (Table 2). In contrast, earlier stage type 1 follicles (Fig. 2a.i,a.ii) exhibited an increased 
proportion of healthy follicles in the 60–140T group and an apparent decrease in atretic follicles in all exposure 
groups (Table 2). At the next developmental stage (Type 2; Fig. 2a.iii), the exposure effect was still evident with 
a significant increase in numbers of Type 2 follicles in the 60–140T group (Table 2). However, the decline in the 
Figure 1. Experimental paradigm to investigate the effects of sludge exposure on the fetal ovary limited to 
80 day periods during early, mid or late gestation. Pregnant ewes were exposed to sewage-sludge fertilized (T) 
pastures from: days 0 to 140 (0–140T, continuous exposure), days 0 to 80 (0–80T, early exposure), days 30 to 110 
(30–110T, mid exposure) and days 60 to 140 (60–140T, late exposure). Control group pregnant ewes (C) were 
maintained on pastures fertilized with inorganic fertilizer from days 0 to 140 of gestation (0–140C).
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proportion of healthy follicles reached significance in only the 30–110T group which also exhibited an increased 
proportion of follicles with intense nuclear staining.
Effects of sludge exposure on the fetal ovarian transcriptome. Gene array analysis revealed that 
256 transcripts (3.4% of 7,500) were differentially expressed (P < 0.05 after Benjamini-Hochberg multiple testing 
correction (FDR at 5%) and absolute fold-change (aFC) > 1.5) between controls and exposed fetal ovaries. Of 
these, 33 were differentially expressed in continuously exposed fetuses (0–140T) but only 4 were differentially 
expressed in the 0–80T group (Fig. 3a and Supplementary Table S2A). In contrast, 99 and 120 transcripts were 
differentially expressed in the 30–110T and 60–140T groups respectively. These exposure periods embrace oocyte 
prophase I meiosis (50–75 dpc in sheep) and follicle formation (75–140 dpc in sheep). In all exposure conditions, 
76% of transcripts were down-regulated (196/256) vs 23% (60/256) upregulated (Fig. 3a). Strikingly, few differ-
entially expressed transcripts were common to two or more periods of exposure; that is the majority were specific 
to single exposure periods (Fig. 3b). For example, only 22 transcripts were altered in any two specific periods and 
only IGHA2 was altered in all four (Fig. 3b, Supplementary Table S2B). Differentially expressed transcripts were 
associated with cellular growth and differentiation, cell cycle regulation, cell death, cellular development, and cell 
movement (IPA analysis; Fig. 3c). These cellular functions are active during follicle formation when pre-granulosa 
cells proliferate and move to surround oocytes. These functions were particularly affected during the 60–140 dpc 
period (Fig. 3c, Supplementary Table S2A). The ERK/MAPK and PI3K/AKT signaling, growth hormone signal-
ing and actin cytoskeleton signaling pathways were the most affected by sewage sludge exposure (Fig. 3d). These 
are all involved in dialogue between germ cells and somatic cells during early folliculogenesis.
Fourteen of the differentially expressed genes are involved in DNA methylation, with 10 identified as methyl 
transferases, 3 as demethylases and 1 as a histone deacetylase subunit (Supplementary Table S3). Significant dif-
ferences were most evident in the late (60–140T) gestation exposure groups. Six of nine differentially expressed 
genes detected by microarray showed identical directional changes (up or down regulation) by qPCR, four of 
which were significant (Supplementary Table S4).
Effects of sewage sludge exposure on the fetal ovarian proteome. Proteomic analyses revealed 
64/776 analyzed protein spots (Fig. 4a), normalized for volume, that were altered (P < 0.05) relative to controls. 
Significantly, 30–110T and 60–140T groups clustered separately from 0–140 C, 0–140T and 0–80T (Fig. 4b). 
In contrast to transcript expression, 83% of these protein spots were up-regulated and, relative to controls, 
the 30–110T and 60–140T groups displayed the greatest number of differentially expressed spots (Fig. 4c). 
Methylenetetrahyrdofolate dehydrogenase 1 (Fig. 4d) and Serotransferrin (Fig. 4e) represent examples of up- and 
down-regulation respectively during the 30–110 and 60–140 periods of exposure (see also Supplementary Table S5). 
Only two protein spots were altered in all treatment groups and these were identified as Lamin A/C and Lamin 
M/C (up-regulated) (Fig. 4f, Supplementary Table S5). We elected to verify quantification for these two proteins 
by Western blot which confirmed that their up-regulation was attributable to the 65 kDa LMNA (LAMIN C) 
product and that this was restricted to the 0–140T, 0–80T and 30–110T groups (Fig. 5a,b, Supplementary Fig. S3). 
Exposure Groups
0–140C 0–140T 0–80T 30–110T 60–140T
Morphology
 No. Ewes carrying ≥ 1 female fetusA 8 5 6 7 7
 No of female fetusesB 9 8 9 11 10
 Fetal weight (kg) 5.01 ± 0.20a 4.59 ± 0.32 4.29 ± 0.25b 4.29 ± 0.27b 3.59 ± 0.33b
Body weight-normalized parameters (/kg)
 AGDC (mm/kg) 2.0 ± 0.2a 1.7 ± 0.1 1.9 ± 0.2 3.3 ± 0.2b 3.1 ± 0.3b
 Ovary (mg/kg) 16.6 ± 2.0 20.1 ± 3.2 19.4 ± 2.6 14.3 ± 0.9 17.5 ± 1.2
 Thyroid (mg/kg) 221 ± 18a 223 ± 20 227 ± 17 265 ± 17 308 ± 26b
 Adrenals (mg/kg) 125 ± 12 115 ± 3 110 ± 8 128 ± 9 156 ± 14
 Uterus (mg/kg) 212 ± 10a 233 ± 16 244 ± 19 217 ± 15 162 ± 11b
 Liver (g/kg) 24.3 ± 0.4a 20.5 ± 1.1b 24.2 ± 1.2 24.9 ± 1.1 28.4 ± 1.7b
Endocrinology
 Testosterone (nmol/l) 2.7 ± 0.1a 3.2 ± 0.3 3.5 ± 0.3b 2.7 ± 0.3 2.3 ± 0.1
 Progesterone (nmol/l) 119 ± 11 102 ± 20 136 ± 18 90 ± 11 132 ± 13
 Free T3 (pmol/l) 2.7 ± 0.2a 3.4 ± 0.4 3.0 ± 0.3 3.2 ± 0.2 1.7 ± 0.2b
 Free T4 (pmol/l) 25.3 ± 1.3a 26.3 ± 2.2 26.7 ± 1.4 27.1 ± 1.4 29.5 ± 1.0b
Table 1.  Morphology and endocrinology of Day 140 female fetuses following exposure to sludge treated 
pastures. A75% of ewes (25/33) carried twin pregnancies. The remaining pregnancies were singleton (n = 3) 
and triplet (n = 5). BFetuses were used from all pregnant ewes (≥ 1 per ewe). CAGD = anogenital distance. 
Values represent mean ± SEM. Experimental groups: C = Control, T = Exposed. Differing superscripts 
indicate differences relative to 0–140C at P < 0.05. Paired organs were combined into a single weight prior to 
normalization against fetal weight.
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In contrast, the 75 kDa product (LAMIN A) was unaffected. Immunocytochemistry revealed that LAMIN 
A/C was noticeable in most cells but was more condensed in granulosa cells than in the oocyte or stromal cells 
(Fig. 5c).
Pathway analysis of the most consistently differentially expressed proteins across all treatments revealed two 
networks primarily concerned with tissue defense and metabolism (Supplementary Table S5). Proteins selected 
from both networks were expressed predominantly in the oocyte cytoplasm (e.g. UCHL1, PDIA3, GSTM3, 
HSPA9 and BLVRA) (Supplementary Fig. S4). In contrast, COPS4 was detected in the nucleus of granulosa cells 
and the cytoplasm of oocytes, whereas GSN was detected in the nucleus of both cell types.
Discussion
The findings from the current study are significant for the following reasons. They identify stages of female-fetal 
gonad development in sheep that are particularly sensitive to environmental-chemical exposure, which in our 
case arose when ewes grazed sewage-sludge treated pastures. Whilst EC exposure reduced the proportion of 
Figure 2. Follicle development in the Day 140 fetal ovary following continuous (0–140T) or transitory 
(0–80T, 30–110T and 60–140T) maternal exposure to sludge treated pastures. (a) Healthy follicle stages in 
developmental order (a.i to a.iii) include Type 1 (primordial), Type 1a (transitory/activated), Type 2 (primary), 
and Type 3 (small-preantral). Atretic follicles (a.iv: cytoplasm shrinkage from granulosa cells, dark coloration) 
and those with intense nuclear staining (INS: a.v). Scale bar = 50 μm. (b) The proportion of healthy Type 
1a follicles was reduced (P < 0.05) in all exposure groups. Separately-counted atretic Type 1a follicles were 
increased (P < 0.05) in all transitory exposure groups. Developmental types: type 0 = isolated or naked oocyte 
(without associated granulosa cells (GC). Follicle types (Lundy et al.46): type 1 = primordial follicle (oocyte 
with flattened GC; type 1a = Transitory/activated follicle (a mixture of flattened and ≥ 1 cuboidal GC; type 
2 = primary follicle (1 to < 2 complete layers of cuboidal GC; type 3 = small pre-antral follicle (2 to < 4 complete 
layers of cuboidal GC); type 4 = large pre-antral follicle (4 to < 6 layers of cuboidal GC); type 5 = small antral 
follicle (> 5 layers cuboidal GC).
www.nature.com/scientificreports/
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healthy primordial/transitory follicles regardless of developmental stage, exposure during the latter stages of ges-
tation led to the most divergent concentrations of fetal liver chemicals and, significantly, differentially expressed 
transcripts and proteins essential for normal ovarian development. Given that AGD was also increased in these 
fetuses, collectively, these observations present the tantalizing prospect that EC exposure from mid pregnancy 
could have a more profound and permanent effect on ovarian function that extends beyond our initial obser-
vations on fetal follicular development to influence fecundity more generally during adulthood. To date these 
long-term consequences have not been explored.
Previous studies by our group assessed the effects of sludge exposure on fetal ovary development continuously 
up to Day 110 of gestation (i.e. for 0.75 of gestation)10,11. Consistent with our current observations, these two 
studies observed a significant reduction in the proportion of Type 1a follicles. Thus we now provide compelling 
evidence from three independent studies that exposure to ECs from sewage sludge profoundly alters early follicle 
development in the fetal ovary. The present study sought to determine if there was a key EC sensitive stage of fetal 
ovarian development, as has been reported for the testis in rodents24. However, it would appear that EC exposure 
during any or all of the stages of gestation studied affects fetal folliculogenesis in a phenotypically similar manner 
(Fig. 2). This could reflect the common period of exposure (i.e. Day 60 to 80; coincident with primordial follicle 
formation) for all treatment groups. In contrast, the greatest differences in both transcript and protein expression 
in the fetal ovary were observed when EC exposure occurred from around mid-gestation (Figs 3 and 4), coin-
ciding with processes of oocyte meiosis through to primary follicle differentiation, leading onto antral-follicle 
formation25.
Exposure Description
Oocyte/follicle proportions (%total oocytes/follicles/follicle class)
0–140C None
0–140T 
Continuous 0–80T Early 30–110T Mid 60–140T Late
No. ovaries assessed 5 8 9 10 9
Type* 0 (n/mm2) 0.35 ± 0.20 1.02 ± 0.42 1.05 ± 0.36 1.57 ± 0.51 0.68 ± 0.27
0.35 ± 0.20 1.02 ± 0.42 1.05 ± 0.36 1.57 ± 0.51 0.68 ± 0.27
Type 0 (%)
 Healthy** 60.7 ± 21.5a 89.8 ± 5.9b 71.0 ± 10.8 82.7 ± 9.7 63.3 ± 10.1
 INS 5.3 ± 3.3 7.1 ± 4.6 10.0 ± 4.3 8.0 ± 5.0 9.9 ± 3.4
 Atretic 34.0 ± 22.7 3.2 ± 2.1 10.0 ± 10.4 9.3 ± 4.9 26.9 ± 8.8
 Type 1 (n/mm2) 3.87 ± 2.61 4.73 ± 1.76 5.81 ± 1.78 7.29 ± 1.83 9.85 ± 4.14
Type 1 (%)
 Healthy 70.1 ± 23.4a 87.2 ± 2.4 92.2 ± 1.5 88.4 ± 2.2 92.4 ± 1.8b
 INS 0.6 ± 0.4 6.6 ± 1.7 6.0 ± 1.5 5.9 ± 2.5 2.9 ± 0.9
 Atretic 29.3 ± 23.6a 6.2 ± 1.8b 1.9 ± 0.5b 5.7 ± 1.3b 4.7 ± 1.5b
 Type 1a (n/mm2) 11.86 ± 4.57 11.67 ± 1.98 11.53 ± 2.79 18.24 ± 2.77 19.56 ± 3.42
Type 1a (%)
 Healthy 98.0 ± 1.0a 91.6 ± 2.2b 89.3 ± 1.5b 86.7 ± 2.5b 91.1 ± 1.2b
 INS 0.7 ± 0.3a 3.0 ± 1.2 3.8 ± 0.8b 3.7 ± 1.1b 2.9 ± 0.4
 Atretic 1.3 ± 0.8a 5.5 ± 1.5 6.9 ± 1.2b 9.6 ± 1.8b 6.0 ± 0.9b
 Type 2 (n/mm2) 1.66 ± 0.29a 1.85 ± 0.54 1.11 ± 0.21 2.29 ± 0.37 4.67 ± 0.83b
Type 2 (%)
 Healthy 96.0 ± 1.1a 85.5 ± 4.8 93.5 ± 2.1 80.4 ± 5.0b 88.4 ± 3.8
 INS 1.0 ± 0.7a 1.2 ± 0.8 1.5 ± 0.8 5.3 ± 0.8b 1.2 ± 0.4
 Atretic 3.0 ± 1.0 13.3 ± 4.5 5.1 ± 2.2 14.4 ± 4.2 10.4 ± 3.9
 Types 3–5 (n/mm2) 0.17 ± 0.06 0.17 ± 0.05 0.22 ± 0.06 0.20 ± 0.06 0.17 ± 0.06
Types 3–5 (%)*** 
 Healthy 100 100 95.7 ± 4.3 90.6 ± 3.9 96.2 ± 2.7
 INS 0 0 0 2.4 ± 1.6 0
 Atretic 0 0 4.3 ± 4.3 7.0 ± 3.9 3.8 ± 2.7
Table 2.  Effects of sewage sludge chemicals on relative proportions of ovarian oocyte/follicle types in day 
140 fetal ovaries. Oocyte/follicle proportions are expressed as a % relative to oocyte/follicle density within 
each follicle class, at different times of gestation. Proportions are shown according to developmental type* 
and health category**; values represent mean ± SEM, differing superscripts indicate statistically significant 
differences vs Control (0–140 C) at p values < 0.05. *Developmental types: type 0 = isolated or naked oocyte 
(without associated granulosa cells (GC)). Follicle types (Lundy et al.46): type 1 = primordial follicle (oocyte 
with flattened GC; type 1a = Transitory/activated follicle (a mixture of flattened and ≥ 1 cuboidal GC; type 
2 = primary follicle (1 to < 2 complete layers of cuboidal GC; type 3 = small pre-antral follicle (2 to < 4 complete 
layers of cuboidal GC); type 4 = large pre-antral follicle (4 to < 6 layers of cuboidal GC); type 5 = small antral 
follicle (> 5 layers cuboidal GC).**Health categories: Healthy, INS = intense nuclear staining and compact 
oocyte nucleus, Atretic = degenerated. ***Types 3–5 combined because of low numbers. P = 0.055 vs control.
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Figure 3. Analysis of differentially expressed (relative to Control) fetal ovarian genes following maternal 
sludge-exposure. (a) More genes were altered following exposure in the 30–110T and 60–140T groups than 
in the 0–140T and 0–80T groups. Only probes that met an FDR of 5% and a threshold of ± 0.7 on the log2 
transformed fold change (LogFC) are displayed. For each exposure, probes were divided into categories 
according to their positive (yellow) or negative (blue) fold change. (b) Venn diagram depicting the number of 
differentially expressed transcripts by exposure group. Few differentially expressed transcripts were common 
to two or more periods of exposure. (c) Functional analysis of differentially expressed transcripts (FDR 
≤ 5%; LogFC threshold ± 0.2) representing a number of specific biological pathways (d) was performed with 
Ingenuity Pathway Analysis (IPA) software. The few transcripts that were altered in the 0–80T group were 
excluded. Significance was computed by Fisher’s exact test and the horizontal blue line corresponds to the 
P-value threshold (P ≤ 0.05).
www.nature.com/scientificreports/
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The increase in AGD observed in 30–110T and 60–140T groups, together with the observed increase in liver 
and decrease in uterine mass for the 60–140T (Table 1) may be indicative of androgenization26–28. In support 
of this, pregnant ewes treated with testosterone propionate (TP) within the same time frame (30–90 days of 
gestation) generated female offspring with increased AGD and a depleted pool of primordial follicles29,30. In 
keeping with the current study, Smith et al.30 also reported an increase in the number of type 2 follicles at day 
140. Collectively these observations implicate a role for androgens in the dysregulation of follicle development. 
However, from the profile of ECs accumulated in the fetal liver (Supplementary Fig. S2) it is difficult to pre-
dict whether a more androgenic environment had been created in our treatment groups. In general, fetal tissue 
concentrations of most PDBE and PCB congeners decreased for these groups; the exceptions being congeners 
PBDE100 and PCB52, which were markedly increased. These two classes of EC are generally considered to have 
Figure 4. Analysis of differentially expressed fetal ovarian proteins following maternal exposure to sludge 
during critical developmental stages. (a) Representative 2-D gel showing significantly altered proteins excised 
for identification by LC-MS/MS (Table S5). (b) Cluster analysis of altered proteins highlights the separation 
between the 0–140C, 0–140T and 0–80T groups from the 30–110T and 60–140T groups. Sludge exposure 
generally increased protein expression across all treatments, particularly in the 30–110T and 60–140T groups (c). 
Representative zoom-boxes and quantification are shown for (d) methylenetetrahydrofolate dehydrogenase 1, 
(e) serotransferrin and (f) Lamin A/C plus M/C. Each treatment group is shown with the protein circled in blue. 
Group means indicated by horizontal green lines. The range of control (0–140C) animals is highlighted by a blue 
bar and those of differing (P < 0.05) treatment groups with an orange bar and a red asterisk.
www.nature.com/scientificreports/
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pro-estrogenic or anti-androgenic actions31. However, the effect of any overall mixture of chemicals depends on 
their precise combination32, so making it difficult to predict the effects of individual ECs in this study.
As previously stated, the transient exposure of pregnant ewes to sewage sludge treated pastures from 30–110 
and 60–140 days led to a greater number of differentially expressed fetal-ovarian transcripts and proteins than 
observed following continuous exposure. In a previous cross-over study, we reported that switching dams from 
control to sewage-sludge treated pastures at conception, and vice versa, also leads to a greater number of altered 
ovarian transcripts at day 110 than observed with continuous exposure11. In both studies, this may reflect altered 
maternal and/or fetal metabolism during pregnancy secondary to changes in pharmacokinetic parameters. One 
possible mechanism is that exposure induced changes in maternal liver, placental and/or fetal liver metabolising 
enzyme expression or activity early in gestation may attenuate the effects of the same chemicals on the late gesta-
tion fetus through adaptive processes. In support of this premise, some human fetal liver DMEs are expressed at 
their highest levels during early pregnancy33 and we have shown in the human that already in the second trimes-
ter the fetal liver responds to challenges, as evinced in our other “real-life” exposure model, maternal cigarette 
smoking34–37. In the current study, pathway analysis of differentially expressed fetal ovarian protein spots high-
lighted drug metabolism as one of the top functions (Supplementary Table S6). Furthermore, a greater number 
of these proteins were altered in the 30–110T and 60–140T groups than in the 0–80T group, or in continu-
ously exposed animals. Transcript analyses also identified differentially expressed DMEs, exemplified by the 
cytochrome P450 (CYP) enzyme genes38. Although in the current model, DME expression in liver (fetal and/
or maternal) or the placenta was not investigated, our observations on fetal ovarian DMEs, suggest that the 
differential expression of DMEs may account for some of the differential effects on fetal outcomes between expo-
sure groups. It is possible therefore that continuous exposure to ECs contained in sewage sludge may have altered 
DME expression differently to that observed in the transient exposure groups. Differential DME expression 
may also account for the differences in EC load between animals exposed for different but overlapping peri-
ods. Consistent with previous studies8,22,23, tissue EC variability may also reflect the complex physiological and 
“between chemical” interactions that occur during maternal ingestion and digestion and the catabolic/anabolic 
status of the individual animal, particularly given the lipophilic property of many ECs.
The 12 signaling pathways significantly altered by sewage sludge exposure (Fig. 3d) were most perturbed in the 
60–140T group. The PI3K/AKT pathway has been identified as a major canonical pathway in quiescent human 
primordial follicles whereas ERK/MAPK becomes enriched in mature metaphase II oocytes39. Both pathways 
are affected in the 60–140T fetal ovaries and the dysregulation of the PTEN/PI3K pathway has been linked to 
ovarian failure and infertility40,41. Extending beyond the ovary, PCB-perturbed thyroid function has been linked 
Figure 5. Quantification and localisation of nuclear laminin proteins. (a) cropped Western blot for 75, 
65 kDa LAMIN A/C and below the blue line, beta-actin load control. The full length images are shown in 
Supplementary Fig. 3 and gels were run under the same experimental conditions. (b) Expression (band 
volume) of 65 kDa LAMIN C increases in sludge-exposed fetal ovaries. The range of control (0–140C) animals 
is highlighted by a blue bar and those of significantly differing treatment groups with an orange bar (P < 0.05) 
and a red asterisk. (c) Immunoreactivity for LAMIN A/C is noticeable in nearly every cell but staining is more 
condensed in pre-granulosa or granulosa cells than in the oocyte or stromal cells.
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to the dysregulation of the insulin/PI3K pathway42,43. Perturbed thyroid development and altered T3 to T4 ratio 
reported in the current study (Table 1) may therefore operate through a similar mechanism.
Since all fetal ovaries were collected at Day 140, the profile of transcripts and proteins expressed at this stage 
reflects a snapshot of mechanistic changes that, by virtue of developmentally regulated gene expression, may not 
relate temporally to the profile of Day 140 follicles. Furthermore, we recognize that the use of whole fetal ovar-
ian tissue rather than isolated ovarian cell types provides an interpretational limitation on the data generated. 
Nevertheless, some useful insights into potential mechanisms of impaired ovarian development can be inferred. 
For example, transcript analyses highlighted cellular processes critical for follicle assembly and development 
(Fig. 3c) and IPA analysis of all transcripts and proteins altered in the 60–140T group predicted a decreased acti-
vation state of these processes (Supplementary Table S7). At a functional level, IPA network analyses highlighted 
roles additional to drug metabolism including free radical scavenging, metabolic disease and amino acid metab-
olism (Supplementary Tables S5 and S6).
The trend for down-regulation of differentially expressed genes in the 30–110T and 60–140T groups is con-
sistent with ECs causing a cascade of events mediated by epigenetic mechanisms leading to the silencing of gene 
expression (reviewed in44). Specific ECs are known to alter epigenetic states including the susceptibility of his-
tone methylation marks to endocrine disruption45. In the current study, 14 genes coding for histone methylation 
(Supplementary Table S3) were differentially expressed while fetal ovarian methylenetetrahydrofolate dehydro-
genase (NADP + dependent) 1 (MTHFD1) protein, a folate-metabolizing enzyme necessary for cellular meth-
ylation, was increased specifically in the 30–110 and 60–140T groups (Fig. 4d, Supplementary Table S5). The 
deregulation of MTHFD1 protein expression could contribute to altered DNA/histone methylation in exposed 
ovaries and lead to perturbed gene expression. To investigate this further, IPA analysis, based entirely on this pro-
tein, and genes encoding epigenetic regulators identified in the current study, predicted a decrease in RNA/DNA 
expression/transcription, an increase in cell proliferation and a decrease in cell death (Supplementary Fig. S5): 
features generally consistent with our experimental observations.
In conclusion, this study demonstrates that the ovine fetal ovary exhibits differential and temporal sensitivity 
to a ‘cocktail’ of chemicals present in sewage sludge treated pastures. Although transitory type 1a pre-primary 
follicle development is sensitive to exposure across all developmental stages, exposure during mid and late ges-
tation induced the most divergent concentrations of liver chemicals coincidentally with the largest number of 
altered ovarian transcripts and proteins. Cellular functions and signaling pathways consistent with follicle acti-
vation and development to the primary follicle stage were perturbed. Transcripts for key epigenetic regulators 
were also altered. Indeed given the overall down-regulation in transcript expression observed, these findings are 
indicative of global epigenetic dysregulation, although this was not determined in the current study. These data, 
however, highlight risks associated with the standard global agricultural practice of grazing livestock on pastures 
fertilized with treated human and industrial effluents. Since low-level chemical exposure poses a threat to human 
reproductive development, the consumption of products from animals grazing such pastures represents a sub-
stantial environmental concern.
Methods
Animals, treatment groups and tissue collection. All experiments were performed in accordance with 
relevant guidelines and regulations and all experimental protocols were approved by the James Hutton Institute’s 
Local Ethical Committee and fully licensed by the United Kingdom’s Animals Scientific Procedures Act 1986 
under Project license authority (60/3356).
Previously unused pastures were fertilized with a single treatment of thermally dried sewage sludge in 
mid-September (2.25 metric tons of dry matter/ha; Treated; T) or with inorganic fertilizer balanced for nitrogen 
(225 kg/ha/year; Control; C). Experimental animals were maintained on either C or T pastures. Mature Texel 
ewes were allocated to one of five treatment groups (Fig. 1) randomly within body condition score class, at the 
beginning of the study. Body condition scoring served as a measure of nutritional state and this was repeated 
at approximately monthly intervals from the time of first mating through to the day of euthanasia. Each group 
initially comprised approximately 14 animals but the results reported concern only those carrying at least one 
female fetus. Ewes of four of the T groups were exposed to sewage sludge-treated pastures from 0–140 days or for 
an 80 day period during early (0–80 days), mid (30–110 days) or late (60–140 days) gestation (Fig. 1). In order 
to manage the exposure of ewes in each of the 5 treatment groups as near-contemporaneously as possible, all 
ewes were mated by Texel rams at the second synchronized estrus following withdrawal of progestagen sponges 
(Chronolone, 30 mg; Intervet, Cambridge, UK). Pregnant ewes were transferred from the Control pastures to 
Treated pastures (and back again), as necessary, to achieve exposure to sludge-treated grasslands during the pre-
scribed periods of gestation. The mating times of each group were calculated to ensure that groups of animals at 
different stages of gestation were exposed to sludge-treated pastures during a similar calendar period (+5 days). 
When pregnant ewes were removed from the treated pasture, they were maintained for a few days on a separate 
area of pasture before returning to the control pastures in order to ensure that contamination of the latter, via 
faeces and urine, was minimized. Animals were condition scored at approximately monthly intervals from the 
time of first mating to provide an index of nutritional state. However, animals were not fed any supplement during 
the study so that they were not exposed to any additional EDCs that might be present in such supplements; all 
ingested nutrients were derived from pasture. Animals of each treatment group were euthanized at Day 140 of 
gestation, according to Schedule 1 protocols, as defined by the UK Animals (Scientific Procedures) Act (1986). 
At slaughter, data and tissues were collected and processed as described previously11. In brief, fetal anogenital 
distance (AGD) was measured and fetal ovary weights recorded. Ovaries were either fixed in neutral buffered for-
malin (NBF) for histological analysis or snap frozen in liquid nitrogen and stored at − 80 °C for protein and RNA 
extraction. Maternal and fetal liver samples were wrapped in aluminum foil and stored at − 20 °C until analysis 
for selected EDCs.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 6:22279 | DOI: 10.1038/srep22279
EDC determinations and hormone assays. Soil samples (approximately 50 cores; 5 cm diameter; 5 cm 
depth) were collected from the pastures at the beginning of the main period of animal exposure, pooled within 
plots and analyzed for selected EDCs to provide an index of animal exposure. Soil and liver samples were ana-
lysed to determine concentrations of selected polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers 
(PBDEs), polycyclic aromatic hydrocarbons (PAHs) and diethyl hexyl phthalate (DEHP) as previously described 
in9. Fetal serum levels of progesterone, total testosterone (bound and unbound), free T3 and free T4 were meas-
ured as previously described11,13 with the automated ADVIA Centaur® XP competitive immunoassay system 
(Siemens Healthcare Diagnostics, Camberley, UK). Progesterone mean intra- and inter-assay CV were 1.9% and 
3.2%, respectively, and the assay sensitivity was 0.67 nmol/l. Total serum testosterone mean intra- and inter-assay 
CV were 4.4% and 6.2%, respectively, and the assay sensitivity was 0.35 nmol/l. Free T3 inter-assay CV was 3.08% 
and assay sensitivity 0.3 pmol/l. Free T4 mean intra- and inter-assay CV were 4.00% and 2.23% respectively and 
the assay sensitivity was 1.3 pmol/l.
Ovarian histomorphology, immunohistochemistry and RNA and protein extraction. After fix-
ing, fetal ovaries were processed as previously described11 and analyzed using the Lundy scale46 to characterize 
follicle types. Two tissue blocks were generated per ovary and from each block, two non-consecutive sections 
(4th and 12th) were stained with hematoxylin and eosin. Six fields of view (images) were taken from the periphery 
of each section at × 200 magnification. Consequently, 24 fields of view were counted for each fetal ovary and 
results calculated as oocyte follicle density (number/mm2). Only those follicles with a visible cross-section of the 
oocyte nucleus were counted. All other follicle numbers were calculated as percent within each follicle class for 
each exposure period (Table 2). Within each oocyte/follicle type, health status was recorded using three catego-
ries: (i) healthy, (ii) intense nuclear staining (INS) of the oocyte, including only those with nuclei that were clearly 
condensed and compact in comparison to healthy surrounding follicles and (iii) atretic, including oocytes/folli-
cles that had degenerated. In many cases, the cytoplasm had shrunk and was detached from the granulosa cells; 
degenerated follicles with INS were also recorded as atretic. Although follicles with very intense dark staining of 
the oocyte nucleus without cytoplasm shrinkage were considered abnormal, the relationship to atresia is uncer-
tain. Consequently, such follicles were characterized differently.
Immunohistochemistry was performed as described, previously47. Two retrieval methods were used to 
expose antigens that may have been masked during fixation of the tissue: a citrate- based (pH 6.0) solution or an 
EDTA-based (pH 8.8) solution. The primary antibody incubation period was 30 min. Where applicable, the Bond 
DAB Enhancer (Leica Microsystems Newcastle Ltd.) was used to maximize clarity by changing the color of the 
diaminobenzidine (DAB) reaction deposit. Antibodies used were (i) Lamin A/C 1/200, mouse (ab49721, Abcam); 
(ii) UCHL1, 3 μg/ml, rabbit (LS-B489/9526, Lifespan Biosciences), (iii) PD1A3 (ERP57); 1:1000 rabbit (ab13507, 
Abcam); (iv) TAGLN, 1 μg/L, goat (AHP2034, ABD Serotec) (v) GSTM3, 1:100 rabbit (15214-1-AP, ProteinTech), 
(vi) GSN, 1 μg/ml mouse (ab55070, Abcam), (vii) HSPA9 (GRP75), 1:200, rabbit (ab53098, Abcam), (viii) COPS4, 
1:25 rabbit (HPA036894, Sigma), (ix) BLVRA, 1:100 rabbit (H00000645-A01, Abnova). Sections were visualized 
with Bond Refine DAB (Leica Microsystems Newcastle Ltd.), washed in water, and counterstained with hema-
toxylin. IgG-negative control sections, exposed to non-immune serum of the relevant species in the absence of 
primary antibody, included in all immunohistochemistry runs showed no positive immunostaining.
Fetal ovarian RNA and protein extraction. RNA and proteins were extracted from ovaries with a 
Qiagen AllPrep DNA/RNA/Protein mini kit (Qiagen Ltd., Crawley, UK). Tissues were homogenized follow-
ing manufacturer’s instructions with two main modifications: i) the addition of protease inhibitors (Protease 
Inhibitor Cocktail, Sigma-Aldrich Company Ltd, Gillingham, UK) to the lysis buffer (RLT) to maximize protein 
integrity and yield and ii) the re-suspension of protein pellets in Modified Reswell Solution11. RNase-free DNase 
I digestion of the RNA was performed following manufacturers’ recommendations (Qiagen Ltd).
Customized ovine microarray and quantitative PCR analysis of gene expression. Transcriptome 
analysis was conducted on a custom 15K Agilent oligo sheep microarray. The catalogue Sheep Gene Expression 
Microarray 8 × 15K (G4813A-019921) was modified by adding new target sequences and removing redundan-
cies. Briefly, redundancies were identified according to sheep ESTs assembly and oligo annotations performed 
by Sigenae (http://www.sigenae.org/). Sheep contigs targeted by several different oligos were identified and the 
best annotated oligos located on the 3′ end of the contig were conserved (a maximum of 2 per contig); the other 
oligos targeting the same transcript were removed from the array. A total of 1,500 new targets were then added to 
the array and oligos were designed according to Agilent “GE Probe Design” eArray workflow and tools (https://
earray.chem.agilent.com/earray/) using the default options (Base Composition Methodology, one oligo par target, 
60bp length, 3′ Bias Design). The array was enriched with transcripts isolated and identified in the fetal develop-
ing sheep ovary by subtractive cDNA library construction (SSH)48 and completed with control genes known to 
be expressed in the female and male developing gonads. New oligos added to the array as well as native Agilent 
oligos maintained on the array were annotated using the Sigenae SigReannot tool49. The final version of anno-
tation showed that the array contained oligos which can be linked to about 7,500 different genes. Labeling and 
hybridization were performed at the “Plate-forme Biopuces et Sequençage” (http://www-microarrays.u-strasbg.
fr/). RNA integrity and quantity was checked, respectively, by Bioanalyzer (Agilent) analysis and Nanodrop 
ND-1000 UV measurement. Labeling and hybridization were carried out using the Quick Amp Labeling kit for 
one-color labeling (Agilent, 5190-0442) and the One-Color RNA Spike-in Kit (Agilent, 5188–5282) according 
to the manufacturer’s instructions with 200 ng of total RNA starting quantities. Arrays were scanned with the 
Agilent DNA Microarray Scanner Model G2565B and image analysis performed with Agilent Feature Extraction 
software v9.5.3.1. In order to verify the quality and hybridization reproducibility of the array, hybridization tests 
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with ovary RNAs from control animals were performed using one-color labelling and standard hybridization: 
70–80% of spots were significantly hybridized and replicate experiments showed good reproducibility.
Confirmatory transcript expression by real-time PCR was determined as previously described47. In brief, 
RNA was treated using RQ1 RNase-free DNase (Promega, Southampton UK) prior to cDNA synthesis using the 
Transcriptor First Strand cDNA Synthesis Kit (Roche, Welwyn Garden City, UK) following the manufacturers 
instructions. Standard curves were generated using 1:5 serial dilutions of pooled cDNA. The cDNA samples were 
diluted 1:50 in dH2O prior to analysis by qPCR. Oligonucelotide primers and hybridisation probes were designed 
using Primer3 software. The DNA probes were synthesised with a 5′ -FAM fluorophore and a 3′ -TAMRA 
quencher (Eurofins, Ebersberg, Germany). Genbank accession numbers and probe and primer sequences are 
listed in Supplementary Table S8.
All qPCR samples were run in triplicate and included a no temple control. qPCR was conducted using the 
LightCycler® 480 Probes Master (Roche) according to the manufacturers instructions. The 20 μl reaction vol-
umes contained 1 × Probes Master mix, 0.5 μM of each primer, 0.1 μM probe and 5 μl cDNA sample. The thermal 
cycling conditions were 10 minutes at 95 °C (initial denaturing), 45 to 55 cycles of 15 seconds at 95 °C, 30 seconds 
at 60 °C and 1 second at 72 °C (data acquisition). The housekeeping genes GAPDH, HPRT and YWHAZ were 
tested for stability using geNorm, NormFinder and ANOVA analysis. The qPCR data was analysed using Roche 
LightCycler480 software and normalised using the geNorm method.
Validation of transcriptomic data by qPCR. Transcripts differentially expressed by array in the 0–140 
day exposure group compared to controls were ordered on the basis of greatest positive and negative fold change. 
Nine genes, including the two most differentially expressed transcripts, were selected to validate the changes 
observed using the microarray. Only transcripts coded by well-annotated genes were selected for this purpose.
Proteomics and Western blotting. Within each treatment group, equal amounts of protein from each 
ovary extract were combined to construct a single protein “pool” for each treatment group. The four protein pools 
were treated with ReadyPrep 2-D Cleanup Kit (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) to remove 
salt and other contaminants according to the manufacturer’s instructions. Equal amounts (between gels and 
groups) of the soluble protein fractions were separated using 2D gel electrophoresis in quadruplicate (n = 4) 
as described10. The pools represent the biological variability between individuals while the quadruplicate gels 
represent the technical variability10,11,34. The gels were analysed using Progenesis SameSpots software, V 6.01 
(Nonlinear Dynamics, Newcastle, UK) which combine the gel quadruplicates and calculated fold-changes and 
significance (by ANOVA of log-normalized values). Differentially expressed protein spots were selected for spot 
cutting once these ANOVA values had been verified (see Statistical Analysis below). Molecular masses and pIs 
of spots of interest were estimated from separate gels electrophoresed with pH and MW markers. Proteins in the 
gel pieces were digested with trypsin and analyzed (see11 for details). Mass lists in the form of Mascot Generic 
Files were created automatically and used as the input for Mascot MS/MS Ions searches of the NCBInr data-
base using the Matrix Science web server (www.matrixscience.com). The default search parameters used were: 
Enzyme = Trypsin, Max. Missed cleavages = 1; Fixed modifications = Carbamidomethyl (C); Variable modifi-
cations = Oxidation (M); Peptide tolerance ± 1.5 Da; MS/MS tolerance ± 0.5 Da; Peptide charge = 2+ and 3+ ; 
Instrument = ESI-TRAP. Statistically significant MOWSE scores and good sequence coverage were considered to 
be positive identifications.
Individual ovary protein extracts were electrophoresed (30 μg protein/lane) on 26-lane 1-DE 4–12% 
Bis-Tris gels (Invitrogen Ltd, Paisley, UK) under reducing conditions (MOPS buffer, Invitrogen) and trans-
ferred to Immobilon™ -FL membranes (Millipore (UK) Ltd, Watford, UK) as described previously10,11. Odyssey 
Two-Colour Protein Molecular Weight Markers (LI-COR Biosciences UK Ltd, Cambridge, UK) were electro-
phoresed in 3 lanes of every gel. The membranes were blocked (1 hr, room temperature) with Odyssey Blocking 
Buffer (927–4000: LICOR + PBS) and were incubated with primary anti-lamin A/C (mouse 1:5,000, AbCam 
AB49721) (diluted in blocking buffer + PBST) at 4 °C overnight. An anti-ACTB (β -Actin) load control of differ-
ing species was used (mouse 1:5,000, AbCam AB8226 or rabbit 1:10,000, Sigma-Aldrich A5060). IRDye® infrared 
secondary antibodies were obtained from LI-COR. Protein bands were visualized using the LI-COR Odyssey® 
Infrared Imaging System and the resulting electronic images were analyzed using TotalLab TL120 software 
(v2008.1; Nonlinear Dynamics Ltd, Newcastle-upon-Tyne, UK) to determine the molecular weights and band 
volumes. The band volumes of ACTB (β -Actin) were compared between treatment groups to check the validity of 
this load control for fetal ovaries from the 4 treatment groups and the controls.
Statistical and array analyses. Unless otherwise stated, data are presented as mean ± s.e.m. Fold-changes 
presented as positive or negative values are indicative of an increase or decrease, respectively, relative to controls. 
Data analyses were performed using JMP 7 (Thomson Learning, London, UK). Normality of data distribution was 
tested with the Shapiro-Wilk test and non-normally distributed data were log or arcsine transformed, the latter 
approach relating to proportional data. Following transformation, the assumptions of the statistical tests were met 
(normality and homogeneity of variance of residuals). Values for control and sewage sludge-exposed groups were 
compared using one-way ANOVA for morphological and endocrine data, 1-DE Western Blot band volumes (nor-
malized relative to ACTB expression separate for each lane) and normalized spot volumes (% of total spot volume 
for each gel separately). A linear mixed model was used to account for litter size effects [fixed effects: number 
of fetuses and treatment, random effect: ewe]. Tissue EDC concentration data were log10 transformed prior to 
analysis. Mean concentrations were compared using ANOVA, with the main effects being treatment and age 
(maternal vs fetal). For gene array, data processing and analysis were conducted using Biocondutor packages suite 
(http://www.bioconductor.org/index.html) and LIMMA package50 with the R statistical program. Raw median 
signal from Feature Extraction array files was used as non-processed signal and log2 transformed. Background 
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was then subtracted locally and intra-array normalization performed by subtracting the array median signal from 
each spot signal on the same array. Multiple testing corrections were applied [Benjamini-Hochberg method51] 
and differentially expressed transcripts were considered under a False Discovery Rate (FDR) of 5%. Functional 
analysis was conducted on transcripts and proteins that exhibited statistically significant, differential expression, 
using Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com/).
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 Supplementary figure S1. Maternal hepatic concentrations of 21 environmentally-relevant 
ECs after sewage sludge exposure. (A) polycyclic aromatic hydrocarbons (PAHs), (B) Di(2-
ethylhexyl)phthalate (DEHP), (C) Polychlorinated biphenyls (PCB), (D) Polybrominated 
Diphenyl Ethers (PBDE). Values for individual livers are shown by circles and the group 
means by horizontal green lines. The range of control (0-140C) animals is highlighted by a 
blue bar and those of significantly differing treatment groups with an orange bar (P<0.05) and 
a red asterisk. Where EDC levels were only above the limit of detection (LOD) in 3 or fewer 
fetuses, the data are not shown (text box). 
 Supplementary figure S2. Fetal hepatic concentrations of 24 environmentally-relevant ECs 
after sewage sludge exposure. (A) polycyclic aromatic hydrocarbons (PAHs), (B) Di(2-
ethylhexyl)phthalate (DEHP), (C) Polychlorinated biphenyls  (PCB), (D) Polybrominated 
Diphenyl Ethers (PBDE). Values for individual fetuses are shown by circles and the group 
means by horizontal green lines. The range of control (0-140C) animals is highlighted by a 
blue bar and those of significantly differing treatment groups with an orange bar (P<0.05) and 
a red asterisk. Where EDC levels were only above the limit of detection (LOD) in 3 or fewer 
fetuses, the data are not shown (text box).  
 
  
Supplementary Figure S3. Full length images (reported in Fig. 5) from a single Western 
blot membrane probed for (a) LAMIN A/C and (b) β-ACTIN as a load control. The two 
frequencies used by the Odyssey imaging system are shown separately rather than merged for 
clarity. The protein TAGLN was also probed prior to the addition of anti-β-ACTIN but 
showed no statistically significant difference between treatment groups and was not reported 
in the main results. 
 
  
Supplementary figure S4. Immunolocalisation of proteins with altered expression in Day 
140 fetal ovaries exposed to sewage sludge at different stages of gestation. Positive staining 
is brown (DAB), counterstained by hematoxylin (blue). The bars denote scale for each image 
separately. Plain white arrows highlight immuno-positive cells. Colored or labeled arrows 
denote features of interest. UCHL1 (A), GSTM3 (D) and HSPA9 (F) were localized to the 
cytoplasm of the oocyte. HSPA9 (F) was also visible in the granulosa cells. PDIA3 (B) was 
principally localized to the oocyte cytoplasm, but also showed some expression in granulosa 
cells. TAGLN (C) was localized to somatic cells, especially mesenchymal cell streams 
although a few probable granulosa cells were also immune-positive. GSN (E) was weakly 
localized to oocyte cytoplasm and to some granulosa and somatic cells. Some staining of 
nuclei was apparent. COPS4 (G) was widely but weakly localized to the cytoplasm of 
oocytes, granulosa cells and some somatic cells around the follicles. In contrast, BLVRA (H) 
was weakly localized principally to oocyte cytoplasm although heavier staining of some 
atretic follicles was observed. In all cases IgG-negative slides incubated with non-immune 
serum of the appropriate species were characterized by an absence of brown stain (I). Scale 
bar = 50µM. 
  
 
Supplementary figure S5. Networks affected by sewage sludge exposure based on 
epigenetic effects on the proteome (Supplementary table 5: MTHFD1) and transcriptome 
(Supplementary table 3:  EZH2, AOF2, ARID4B, EHMT2, KDM5B, MLL, MLL3, PRMT7, 
SETDB1, SETDB2, SUV420H2, UTX, WHSC1L1) of the 30-110 and 60-140 groups 
combined compared with control (0-140C). Analysis was performed using IPA.  
  
Supplementary Table S1: Effects of sludge exposure on soil concentrations of individual 
polycyclic aromatic hydrocarbons (PAH). 
PAH in Soil (µg/kg of dry matter) Changes in PAH relative to 
Controls 
 Control
A
 
n=1  
Treated
A
 
n=3
C
 
Maternal liver Fetal Liver  
Naphthalene 23.1 80.6 ± 22.3 ↑60-140 <LODB 
Acenaphthalene 5.1 8.6 ± 4.2 No Change <LOD 
Acenaphthene 11.9 27.4 ± 12.0 ↑30-110 <LOD 
Fluorene 10.8 36.9 ± 15.3 No Change No Change 
Benzo[a]anthracene 
 
121.7 
 
235.6 ± 84.1 ↓30-110, 
↓60-140 
↓30-110 
Chrysene 
 
192.1 
 
310.3 ± 112.3 
 
↓30-110, 
↓60-140 
No Change 
Benzo[k]fluoranthene 126.3 170.1 ± 63.6 ↑60-140 <LOD 
Benzo[a]pyrene 130.6 163.4 ± 57.7 No Change No Change 
Benzo[ghi]perylene 54.5 135.6 ± 61.1 No Change No Change 
A
Soil samples were taken in December from 1 control and 3 sewage sludge treated pastures. 
B
Below limit of detection, CMean ± SEM 
Supplementary table S2: Fetal ovarian genes altered by sewage sludge exposure of ewes:  
(A) Ovarian genes altered following exposure throughout gestation (0-140 days) or during different periods of gestation: early (0-80 
days), mid (30-110 days) and late (60-140 days) gestation. 
 
0-140C vs 0-140T (33 differential probes): 
  
Agilent Probe 
Name 
Target EST Accession Ensembl Gene ID 
Gene 
Symbol 
Log Fold 
Change 
Up-regulated 
genes 
A_70_P001791 EE768843, NR_036644.1 - RN28S1 1.84 
BL_UN4_F000144 CD288357, NR_036644.1 - RN28S1 1.83 
BL_OCA_X000661 EE800761, NR_036644.1 - RN28S1 1.24 
BL_OTH_F000135 AJ874675 MHC class I antigen, Multiple targets 1.22 
A_70_P068241 AJ874684, EF489531 ENSBTAG00000018701 LOC616942 1.01 
A_70_P070391 EE818692 ENSBTAG00000017021 MCM4 0.96 
A_70_P057546 EE830287 ENSBTAG00000011595 IHPK1 0.94 
BL_OCA_X000220 EE747067 ENSBTAG00000000836 P05786 0.87 
A_70_P037711 EE773783 ENSBTAG00000002728 ARID1B 0.85 
BL_UN4_R000141 CD286372 ENSBTAG00000014490 BAT1 0.82 
A_70_P040451 EE828873 ENSBTAG00000004899 ABLIM 0.82 
A_70_P021386 EE829899 ENSBTAG00000000599 CCNI 0.79 
A_70_P021286 EE751423 ENSBTAG00000021880 CABC1 0.76 
A_70_P007651 EE820840 ENSBTAG00000005064 WARS2 0.75 
A_70_P071491 EE821931 ENSBTAG00000002389 MED19 0.73 
A_70_P007676 EE822384 ENSBTAG00000016448 ZBTB40 0.72 
BL_OCA_R000130 CU653858 ENSBTAG00000008022 PTGFRN 0.72 
BL_OCA_X000861 EE750663 ENSBTAG00000015114 CALR 0.72 
Down-regulated 
genes 
BL_OCA_X000085 EE863690 ENSBTAG00000001403 PRKCI -0.71 
A_70_P025386 FE022182 ENSBTAG00000026307 ZNF629 -0.72 
BL_OCA_F000886 S80867 ENSBTAG00000014567 MYLK -0.72 
A_70_P030096 NM_001009744, AF254119 ENSBTAG00000016947 AGTR1 -0.73 
A_70_P007591 FE021553 ENSBTAG00000017085 AGA -0.78 
A_70_P010686 EE755709 ENSBTAG00000010529 FZD6 -0.78 
A_70_P014071 FE025905 - - -0.90 
A_70_P033336 DY486945 ENSBTAG00000012638 S100A12 -1.03 
A_70_P066546 FE035791 ENSBTAG00000003747 PTGR2 -1.03 
A_70_P011801 FE030747 - - -1.16 
BL_OTH_R000040 CF116541 ENSBTAG00000007900 FIS1 -1.16 
A_70_P008296 CN821983 ENSG00000185222 WBP5 -1.19 
A_70_P026671 
EE748059, EE746827, 
EE750802 
ENSG00000211895 IGHA1 -1.46 
BL_OTH_R000484 FE028592 ENSBTAG00000001308 LOC522763 -2.02 
A_70_P041321 AF024645 ENSG00000211890 IGHA2 -2.13 
 
0-140C vs 0-80T (4 differential probes): 
  
Agilent Probe 
Name 
Target EST Accession Ensembl Gene ID 
Gene 
Symbol 
Log Fold 
Change 
Up-regulated 
gene 
BL_OTH_F000135 AJ874675 Multiple Targets 1.17 
Down-regulated 
genes 
A_70_P026671 EE748059, EE746827, EE750802 ENSG00000211895 IGHA1 -1.48 
A_70_P056141 EE835840 - - -1.64 
A_70_P041321 AF024645 ENSG00000211890 IGHA2 -2.03 
 
0-140C vs 30-110T (99 differential probes): 
  
Agilent Probe 
Name 
Target EST Accession Ensembl Gene ID 
Gene 
Symbol 
Log Fold 
Change 
Up-regulated 
genes 
A_70_P031731 FE021050 - - 1.68 
A_70_P069011 EE754635 - - 1.27 
A_70_P019481 EE828813 ENSBTAG00000007113 TRRAP 1.26 
A_70_P043666 EE794724 ENSBTAG00000009374 PARP2 1.02 
A_70_P063496 EE777917 ENSBTAG00000002609 TMIGD1 0.98 
BL_CTL_F000095 NM_001110098 ENSBTAG00000040202 JY-1 0.96 
BL_OTH_F000135 AJ874675 Multiple Targets 0.95 
BL_UN4_R000112 CU655439 - - 0.93 
A_70_P061621 EE749065 ENSBTAG00000005810 PDZK1 0.85 
A_70_P061896 EE805549 ENSBTAG00000014595 LIG1 0.84 
A_70_P056847 M34674 ENSBTAG00000002069 P13752 0.82 
BL_OTH_R000570 CU653314 ENSBTAG00000016548 TEX12 0.81 
A_70_P011466 EE783134 - - 0.81 
BL_OCA_R000236 CU653314 ENSBTAG00000016548 TEX12 0.81 
A_70_P060631 EE853499 ENSBTAG00000030920 A8MWK0 0.80 
A_70_P006731 FE030420 - - 0.80 
BL_OCA_R000096 CU653146 ENSG00000167634 NLRP7 0.80 
BL_UN4_R000134 EE834952 - - 0.79 
A_70_P019141 EE812382 ENSBTAG00000010922 TRAPPC2 0.78 
A_70_P017891 EE748738 ENSBTAG00000007079 LCP1 0.76 
A_70_P041246 AF065146 ENSBTAG00000012290 SCNN1B 0.75 
A_70_P038456 CN824507 ENSBTAG00000012393 AGT 0.75 
A_70_P053296 EE829589 ENSBTAG00000023963 RHBDD1 0.74 
BL_OCA_R000007 CU637765 ENSG00000167634 NLRP7 0.74 
A_70_P001091 FE027551 - - 0.73 
BL_OTH_F001109 EE855194 ENSBTAG00000024219 TRPV6 0.72 
A_70_P012986 EE848845 ENSBTAG00000019460 MOXD1 0.71 
BL_CTL_F000043 CU652732 ENSBTAG00000016272 TEX11 0.71 
Down-regulated 
genes 
A_70_P018781 EE783518 ENSBTAG00000009584 SAPS3 -0.70 
A_70_P068856 EE792088 ENSBTAG00000010123 APOE -0.71 
BL_UN4_R000010 CU638079 - - -0.71 
A_70_P037101 EE773698 ENSBTAG00000013801 PBX1 -0.71 
A_70_P069291 EE823361 ENSBTAG00000026111 LBH -0.71 
A_70_P011496 DY501713 ENSBTAG00000004261 SPON2 -0.71 
A_70_P064761 EE794068 - - -0.71 
BL_OCA_X000467 EE748868 ENSBTAG00000020309 G3BP1 -0.71 
BL_OTH_R000161 DY498768 ENSBTAG00000009491* WDR74 -0.71 
A_70_P072016 FE036025 ENSBTAG00000000146 FARP1 -0.72 
BL_OTH_F000355 CF116331 ENSBTAG00000016649 CCND2 -0.72 
A_70_P008296 CN821983 ENSG00000185222 WBP5 -0.72 
A_70_P008616 EE826054 ENSBTAG00000005586 GATM -0.72 
A_70_P042816 EE756509 ENSBTAG00000003825 PTPN12 -0.72 
BL_OCA_R000262 EE789197 - - -0.72 
A_70_P000006 EE752115 ENSBTAG00000000088 ALCAM -0.73 
A_70_P068551 DY507846 ENSBTAG00000019517 ELN -0.73 
A_70_P027011 CN824409 - - -0.74 
A_70_P017371 EE756026 ENSBTAG00000033487 C4orf46 -0.74 
BL_OCA_X000834 EE754453 ENSBTAG00000026836 ABI3BP -0.74 
A_70_P015531 FE024895 ENSBTAG00000003851 CCNL1 -0.74 
BL_OCA_X000741 EE833401 ENSBTAG00000019839 LTBP1 -0.74 
A_70_P065771 EE758227 ENSBTAG00000010531 CYP1B1 -0.75 
BL_OCA_F000079 CU637962 ENSBTAG00000004115 MYLIP -0.76 
A_70_P040696 EE797585 - - -0.76 
BL_OTH_F000631 DY481166 ENSBTAG00000005077 CXCL12 -0.76 
A_70_P005636 EE784504 ENSBTAG00000015844 TFPI2 -0.77 
BL_OCA_F000053 CF118379 ENSBTAG00000016420 CTNNB1 -0.77 
A_70_P057331 EE827130 ENSBTAG00000003708 SEC23A -0.77 
BL_OCA_X000507 CU652926 ENSBTAG00000027625 SFRP1 -0.78 
A_70_P059406 EE793510 ENSBTAG00000030435 PNRC2 -0.78 
A_70_P013441 DY492813 ENSBTAG00000014874 FYTTD1 -0.79 
A_70_P007006 EE778135 ENSBTAG00000012615 ZEB2 -0.79 
A_70_P046971 EE874463 ENSBTAG00000019472 NR3C1 -0.79 
A_70_P048981 EE772304 - - -0.79 
BL_UN1_R000020 CU653226 ENSBTAG00000030164* RPL38 -0.79 
BL_OCA_F000394 EE755870 ENSBTAG00000014804 HNRPDL -0.81 
A_70_P055581 EE784477 ENSBTAG00000001142 GNE -0.82 
BL_OCA_X000696 EE853694 ENSBTAG00000016420 CTNNB1 -0.82 
A_70_P018376 DY478124 ENSBTAG00000008140 FAP -0.83 
BL_OCA_F000362 DY492542 ENSBTAG00000008140 FAP -0.83 
A_70_P059986 EE782950 ENSBTAG00000002006 THBS1 -0.85 
A_70_P061311 EE872562 ENSBTAG00000010818 AEBP2 -0.87 
BL_OTH_F000664 DY483719 ENSBTAG00000009778 NRAS -0.87 
A_70_P010686 EE755709 ENSBTAG00000010529 FZD6 -0.87 
A_70_P062621 EE760476 - - -0.88 
A_70_P065511 EE862970 - - -0.89 
A_70_P029356 EE785047 ENSBTAG00000011613 PLS3 -0.89 
A_70_P054711 EE770225 ENSBTAG00000017294 ORM1 -0.89 
BL_OTH_F000609 DY479198 Multiple Targets -0.89 
BL_UN1_F000003 CD288332 - - -0.90 
A_70_P019541 EE785539 ENSBTAG00000000184 EIF2AK3 -0.90 
A_70_P053301 EE830605 ENSBTAG00000007718 TGIF1 -0.91 
A_70_P070886 EE812808 ENSBTAG00000016045 TRIB2 -0.92 
A_70_P039196 EE795086 - - -0.92 
A_70_P057416 EE792423 ENSBTAG00000038434 ATRX -0.93 
BL_UN3_R000075 CU655351 ENSBTAG00000001391 ANKRD42 -0.93 
BL_OCA_R000066 CU652331 ENSBTAG00000026851 FMNL2 -0.95 
A_70_P001016 FE027322 ENSBTAG00000005969 EIF2S2 -0.97 
BL_OCA_X000760 EE767289 ENSBTAG00000021965 SUB1 -0.97 
A_70_P017906 EE836165 ENSBTAG00000002317 PTN -0.97 
A_70_P050511 EE784082 ENSBTAG00000007244 NID1 -0.98 
BL_OTH_F000056 AF233078 ENSBTAG00000020935 HIF1A -1.00 
A_70_P053466 EE785467 ENSBTAG00000001851  CES1 -1.00 
A_70_P060796 DY475743 ENSBTAG00000017745 IL6ST -1.04 
A_70_P072071 FE036440 ENSBTAG00000013410 MARK3 -1.13 
A_70_P054061 EE831688 ENSBTAG00000010166 MICB -1.19 
BL_OTH_F000234 CD286927 ENSBTAG00000018271 SLC38A10 -1.22 
A_70_P032741 CF116713 ENSBTAG00000038218  DEFB -1.31 
A_70_P041321 AF024645 ENSG00000211890 IGHA2 -1.58 
BL_OTH_F000260 CD287559 ENSBTAG00000002069 BOLA -2.09 
* = probe complementary to reverse strand hit 
 
0-140C vs 60-140T (120 differential probes): 
  
Agilent Probe 
Name 
Target EST Accession Ensembl Gene ID Gene Symbol 
Log Fold 
Change 
Up-regulated 
genes 
A_70_P031731 FE021050 - - 1.04 
A_70_P001791 EE768843, NR_036644.1 - RN28S1 1.01 
A_70_P019451 EE788143 ENSBTAG00000023411 LOC525947 0.92 
A_70_P070391 EE818692 ENSBTAG00000017021 MCM4 0.89 
A_70_P040451 EE828873 ENSBTAG00000004899 ABLIM1 0.83 
A_70_P043666 EE794724 ENSBTAG00000009374 PARP2 0.82 
A_70_P015131 EE828323 ENSBTAG00000012030 TTLL1 0.78 
A_70_P056176 EE869234 ENSBTAG00000001322 FAM154A 0.77 
A_70_P055321 DY491905 ENSBTAG00000010170 MBTPS1 0.77 
A_70_P017481 EE770023 ENSBTAG00000013526 EFTUD2 0.73 
A_70_P016641 NM_001078128, DY499458 - SOX4 0.72 
A_70_P021286 EE751423 ENSBTAG00000021880 CABC1 0.72 
A_70_P047651 EE819067 ENSBTAG00000008758 KIF20A 0.70 
Down-regulated 
genes 
A_70_P060641 EE753991 ENSBTAG00000011082 IGF1 -0.70 
BL_OCA_F000516 CD286499 ENSBTAG00000020060 TXNIP -0.70 
A_70_P072016 FE036025 ENSBTAG00000000146 FARP1 -0.70 
BL_OTH_F001418 U03092 Multiple Targets -0.70 
A_70_P047171 EE853535 ENSBTAG00000020420 AP1S2 -0.71 
A_70_P066866 EE874417 ENSBTAG00000016229 KLF9 -0.71 
A_70_P060651 EE849613 ENSBTAG00000024888 PDE5A -0.71 
BL_UN4_F000130 EE782267 - - -0.71 
BL_OCA_X000465 EE772496 ENSBTAG00000014024 POMP -0.71 
BL_UN4_R000131 EE786340 ENSBTAG00000016486 SORBS2 -0.72 
A_70_P034416 FE023178 ENSBTAG00000012411 HAPLN1 -0.72 
A_70_P040476 EE795125 ENSBTAG00000038495 DCAMKL1 -0.72 
A_70_P045201 EE789555 ENSBTAG00000024700 CYP2C19 -0.72 
BL_CTL_F000097 U30299 ENSBTAG00000007159 ESR1 -0.73 
BL_OTH_F001373 NM_001082596 ENSBTAG00000015356 TAC1 -0.73 
BL_UN3_R000077 CU655415 - - -0.73 
A_70_P046361 EE771637 ENSBTAG00000022699 CAV3 -0.73 
BL_OCA_R000064 CU652314 - - -0.73 
A_70_P032316 EE843892 ENSBTAG00000031707 FRMD6 -0.74 
A_70_P001046 FE027431 - - -0.74 
A_70_P039641 NM_001078657, DQ886530 ENSBTAG00000017704 ABCG2 -0.74 
BL_OCA_F000774 DY494205 ENSBTAG00000014764 CD9 -0.74 
BL_OTH_R000064 CN823747 ENSBTAG00000021211* DPT -0.74 
A_70_P053466 EE785467 ENSBTAG00000001851  CES1 -0.75 
BL_UN4_R000152 CU651873 ENSBTAG00000020338 CCT6B -0.75 
A_70_P038771 EE782257 ENSG00000112773 FAM46A -0.75 
BL_OCA_X000260 AF395335 ENSBTAG00000019866 NRP1 -0.76 
A_70_P024051 EE834617, FE031091 ENSBTAG00000005726 HNRNPA2B1 -0.76 
A_70_P044826 FE029955 - - -0.76 
A_70_P069221 EE771985 ENSBTAG00000044017 MSRB3 -0.76 
A_70_P040531 EE841180 ENSBTAG00000001862 PPP2R2B -0.76 
A_70_P043556 EE771614 - - -0.76 
A_70_P030701 EE798501 ENSBTAG00000015794 NES -0.76 
A_70_P065851 EE756749 ENSBTAG00000009717 FGL2 -0.76 
BL_OTH_R000235 EE758818 ENSBTAG00000000460 SYTL2 -0.76 
BL_OCA_F000341 DY481807 ENSBTAG00000017704 ABCG2 -0.77 
BL_OTH_F000425 CF118005 ENSBTAG00000027020 COL5A2 -0.77 
BL_UN3_F000051 CU653839 ENSBTAG00000013136 EFCAB11 -0.77 
A_70_P011801 FE030747 - - -0.78 
BL_OTH_F000218 CD286513 ENSBTAG00000014614 ACTA2 -0.78 
BL_OTH_R000299 EE772675 ENSBTAG00000001443* CYP21A2 -0.79 
A_70_P021241 DY482518 - - -0.80 
A_70_P067996 DQ336700 ENSBTAG00000000128 FGF18 -0.80 
A_70_P062066 EE864468 ENSBTAG00000012036 HR -0.80 
A_70_P016731 CN823173 ENSBTAG00000022890 MBP -0.80 
A_70_P020946 EE835047 ENSBTAG00000037811 CCL2 -0.80 
BL_OCA_X000521 CU654365 ENSBTAG00000012545 CASC4 -0.81 
A_70_P065561 EE753822 ENSBTAG00000007089 FRG1 -0.81 
A_70_P066736 EE775565 ENSBTAG00000015204 SMPX -0.81 
BL_OTH_F000431 CF118159 ENSBTAG00000012994 LOX -0.82 
A_70_P016916 AF228667 ENSBTAG00000012855 LPL -0.82 
BL_UN4_F000069 CU653154 ENSBTAG00000000545 SMEK2 -0.82 
BL_OTH_R000230 EE758534 ENSBTAG00000000442* RBP4 -0.82 
A_70_P060871 EE752485 ENSBTAG00000019587 PI15 -0.83 
BL_OCA_F000886 S80867 ENSBTAG00000014567 MYLK -0.84 
A_70_P065771 EE758227 ENSBTAG00000010531 
CYP 
1B1 
-0.84 
A_70_P027206 EE767632 ENSBTAG00000010909 SLC30A1 -0.84 
A_70_P000531 EE753209 - - -0.85 
BL_OTH_F000630 DY480883 ENSBTAG00000011328 CGREF1 -0.86 
BL_OTH_R000040 CF116541 ENSBTAG00000007900 FIS1 -0.86 
A_70_P055351 DY491962 ENSBTAG00000017866 CD36 -0.86 
A_70_P066546 FE035791 - - -0.86 
A_70_P044621 FE023305 ENSBTAG00000024091 MALL -0.87 
BL_OTH_F000559 DY476231 ENSBTAG00000005353 DES -0.87 
A_70_P006546 EE865965 - - -0.87 
A_70_P058711 DY491484 ENSBTAG00000017863 SRGN -0.88 
A_70_P059261 EE867186 ENSBTAG00000021176 CRISPLD2 -0.88 
BL_OCA_R000256 EE776342 ENSBTAG00000006416 TMEM85 -0.88 
A_70_P062621 EE760476 - - -0.88 
BL_OCA_X000687 DY510754 ENSBTAG00000007988 STX2 -0.89 
A_70_P032696 EE864067 ENSBTAG00000000078 GLIPR2 -0.89 
A_70_P032741 CF116713 ENSBTAG00000038218  DEFB -0.90 
A_70_P022381 EE863953 ENSBTAG00000015082 FKBP5 -0.90 
BL_OCA_F000025 CD287139 ENSBTAG00000002457 SEC61B -0.91 
A_70_P065511 EE862970 - - -0.91 
BL_OTH_R000590 EE776342 ENSBTAG00000006416 TMEM85 -0,.92 
BL_OCA_F000043 CF116963 ENSBTAG00000038495 DCLK1 -0.92 
BL_OTH_F000475 CN823734 ENSBTAG00000009863 BHLHE40 -0.93 
BL_OTH_R000192 DY519453 ENSBTAG00000021951* RBM17 -0.93 
A_70_P018256 DY493431 ENSBTAG00000019203 S100A4 -0.94 
A_70_P063336 EE783131 ENSBTAG00000007596 GEM -0.95 
A_70_P042076 EE750097 ENSBTAG00000025398 UBD -0.95 
A_70_P057331 EE827130 ENSBTAG00000003708 SEC23A -0.95 
BL_OTH_F001344 NM_001009804 ENSBTAG00000010565 CYM -0.99 
BL_OTH_F001032 EE786654 ENSBTAG00000009876 C4BPA -1.00 
BL_OTH_F000325 CD289313 ENSBTAG00000015441 ACTG2 -1.00 
BL_OTH_F001400 EE784427 Multiple Targets -1.01 
A_70_P008296 CN821983 ENSG00000185222 WBP5 -1.01 
A_70_P062061 EE805740 - - -1.03 
BL_OTH_F000497 DQ022555 ENSBTAG00000001755 NEUROD1 -1.08 
A_70_P064081 EE858717 ENSBTAG00000017969 CA4 -1.09 
A_70_P026671 EE748059, EE746827, EE750802 ENSG00000211895 IGHA1 -1.10 
A_70_P031966 EE757951 ENSBTAG00000021906 COL29A1 -1.11 
A_70_P017591 EE753919 ENSBTAG00000009876 C4BPA -1.14 
BL_OTH_F000727 DY490965 ENSBTAG00000009812 CXCL5 -1.14 
BL_UN4_R000008 CU638020 - - -1.19 
A_70_P012541 NM_001009456, AY327118 ENSBTAG00000011207 CNN1 -1.21 
BL_OTH_R000503 FE030901 ENSBTAG00000021141 CD8A -1.22 
A_70_P053486 FE031722 - - -1.29 
A_70_P031786 EE755865 ENSBTAG00000002069 BOLA -1.39 
A_70_P005526 CO202686 ENSBTAG00000020099 STMN2 -1.41 
A_70_P054061 EE831688 ENSBTAG00000010166 MICB -1.44 
A_70_P062081 EE778788 ENSBTAG00000021615 LGALS2 -1.53 
A_70_P041321 AF024645 ENSG00000211890 IGHA2 -1.60 
A_70_P024826 EE866305 ENSBTAG00000034885 LOC614348 -1.61 
A_70_P035986 DY505634 ENSBTAG00000015366 SFRP4 -1.63 
A_70_P037831 EE770918 ENSBTAG00000012208 BT.62645 -1.67 
* = probe complementary to reverse strand hit 
 
(B) Differentially expressed fetal ovarian genes altered in two or more periods of exposure.  
 
Agilent Probe 
Name 
Target EST 
Accession 
Sigenae Contig 
Accession 
Ensembl Gene ID 
Gene 
Symbol 
Log Fold Change 
 
0-140T 0-80T 30-110T 60-140T 
Common to all 
conditions 
A_70_P041321 AF024645 AF024645.p.ov.7 ENSG00000211890 IGHA2 -2.13 -2.03 -1.58 -1.60 
Common 0-140T 
and 30-110T 
and 60-140T  
A_70_P008296 CN821983 CN821983.p.ov.7 ENSG00000185222 WBP5 -1.19  - -0.72 -1.01 
Common 0-140T 
and 0-80T and 
30-110T 
BL_OTH_F00013
5 
AJ874675 AJ874675.p.ov.7 Multiple Targets 1,22 1,17 0,95  - 
Common 0-140T 
and 0-80T and 
60-140T 
A_70_P026671 
EE748059, EE746827, 
EE750802 
EE748059.p.ov.7 ENSG00000211895 IGHA1 -1.46 -1.48  - -1.10 
Common 0-140T 
and 30-110T 
A_70_P010686 EE755709 EE755452.p.ov.7 ENSBTAG00000010529 FZD6 -0.78  - -0.87  - 
Common 0-140T 
and 60-140T 
A_70_P001791 
EE768843, 
NR_036644.1 
CF118064.p.ov.7 - RN28S1 1.84  -  - 1.01 
A_70_P070391 EE818692 DY508444.p.ov.7 ENSBTAG00000017021 MCM4 0.96  -  - 0.89 
A_70_P040451 EE828873 EE794958.p.ov.7 ENSBTAG00000004899 ABLIM 0.82  -  - 0.83 
A_70_P021286 EE751423 DY482076.p.ov.7 ENSBTAG00000021880 CABC1 0.76  -  - 0.72 
BL_OCA_F00088
6 
S80867 S80867.p.ov.7 ENSBTAG00000014567 MYLK -0.72  -  - -0.84 
A_70_P066546 FE035791 EE852996.p.ov.7 - - -1.03  -  - -0.86 
A_70_P011801 FE030747 FE030747.p.ov.7 - - -1.16  -  - -0.78 
BL_OTH_R00004
0 
CF116541 CF116541.p.ov.7 ENSBTAG00000007900 FIS1 -1.16  -  - -0.86 
Common 30-
110T and 60-
140T 
A_70_P031731 FE021050 FE021050.p.ov.7 -  -  -  - 1.68 1.04 
A_70_P043666 EE794724 EE794724.p.ov.7 ENSBTAG00000009374 PARP2  -  - 1.02 0.82 
A_70_P072016 FE036025 FE036024.p.ov.7 ENSBTAG00000000146 FARP1  -  - -0.72 -0.70 
A_70_P065771 EE758227 DY475709.p.ov.7 ENSBTAG00000010531 CYP1B1  -  - -0.75 -0.84 
A_70_P057331 EE827130 EE827130.p.ov.7 ENSBTAG00000003708 SEC23A  -  - -0.77 -0.95 
A_70_P062621 EE760476 EE760476.p.ov.7 - miR-450  -  - -0.88 -0.88 
A_70_P065511 EE862970 EE753673.p.ov.7 ENSBTAG00000008114  CD99  -  - -0.89 -0.91 
A_70_P053466 EE785467 EE751403.p.ov.7 ENSBTAG00000001851  CES1  -  - -1.00 -0.75 
A_70_P054061 EE831688 DY513733.p.ov.7 ENSBTAG00000010166 MICB  -  - -1.19 -1.44 
 
 
  
Supplementary Table S3: Fetal ovarian epigenetic genes altered by sewage sludge exposure of pregnant ewes.
a
  
Agilent Probe 
Name 
Target EST 
Accession 
Ensembl Gene ID Gene 
Symbol 
Log 2 (log Fold Change): Function 
0-140 0-80 30-110 60-140  
A_70_P033491 EE750171 ENSBTAG00000009426 EZH2 0.39 ** 0.26 0.23 0.33** Histone-lysine N-methyltransferase 
BL_OCA_X0005
27 
EE774236 ENSBTAG00000009500 AOF2 0.38* 0.1 0.31** 0.25* Lysine-specific Histone 
demethylase 1 
BL_OTH_R0003
89 
EE847497 ENSBTAG00000000222 ARID4B 0.14 0.02 0.44* -0,17 Subunit of the histone deacetylase 
A_70_P042586 EE827530 ENSBTAG00000005676 EHMT2 -0.11 -0.06 -0.32** 0.26 * Histone-lysine N-methyltransferase 
BL_OCA_R0001
70 
CU655258 ENSBTAG00000006175 KDM5B 0.32 0.22 0.22 0.51** Histone  lysine demethylase 5b 
A_70_P002341 EE748251 ENSBTAG00000018093 MLL 0.50 0.36 -0.54 * 0.24 Histone-lysine N-methyltransferase 
BL_OCA_R0000
81 
CU652728 ENSBTAG00000024199 MLL3 0.57 ** 0.12 0.17 0.44** Histone-lysine N-methyltransferase 
A_70_P004941 EE809202 ENSBTAG00000009638 PRMT7 0.35 0.13 0.36 0.52** Protein arginine methyltransferase 
7 
A_70_P022221 EE831325, 
EE828660 
ENSBTAG00000009638 PRMT7 0.41** 0.11 -0.07 0.29 Protein arginine methyltransferase 
7 
A_70_P007511 EE803673 ENSBTAG00000000098 SETDB1 0.38** 0.26 0.32** 0.39 ** Histone-lysine N-methyltransferase 
BL_UN1_F0000
25 
CU655032 ENSBTAG00000007329 SETDB2 -0.15 0.02 0.03 -0.31** Histone-lysine N-methyltransferase 
A_70_P067526 EE805493 ENSBTAG00000014087 SUV420
H2 
0.23 0.09 0.03 0.57** Histone-lysine N-methyltransferase 
BL_OCA_X0000
25 
EE811730 ENSBTAG00000003740 UTX -0.30* 0 -0.35** -0.18 H3K27 demethylase 
A_70_P003906 FE021066 ENSBTAG00000001529 WHSC1
L1 
0.02 0.1 -0.11 0.33* Histone-lysine N-methyltransferase 
a
Ewes were exposed throughout gestation (0-140 days) or during different periods of gestation: early (0-80 days), mid (30-110 days) and late 
(60-140 days) gestation.** p ≤ 0.05, * p ≤ 0.1 
Supplementary Table S4: Fetal ovarian differentially expressed genes detected by microarray with follow up analysis by real time PCR.  
 
Gene Microarray Real time PCR 
Group comparisons  LogFC Fold 
change 
P value Group comparisons Fold 
change 
P value 
Ig heavy α 2 (IGHA2) 0-140C vs 0-140T -2.13 4.39  0.012486 
 
0-140C vs 0-140T 8.08  0.006 
Calreticulin (CALR) 0-140C vs 0-140T 0.72 1.64  0.010258 
 
0-140C vs 0-140T 1 .0 NS 
Prostaglandin R assoc. 
protein (PTGFRN) 
0-140C vs 0-140T 0.72 1.65  0.032037 
 
0-140C vs 0-140T 1.04  NS 
MHC class I HLA-B 
(LOC616942) 
A_70_P068241 
0-140C vs 0-140T 1.01 2.01   0.031971 
 
0-140C vs 0-140T 1.46  NS 
28s RNA (RN28S1) 
A_70_P001791 
0-140C vs 0-140T 1.8359 3.57   0.006109 
 
0-140C vs 0-140T 1.47  0.028 
AGT 
A_70_P038456 
0-140C vs 30-110T 1.6829 0.75  0.005004 0-140C vs 30-110T 
 
3.2  
 
0.0098 
 
AGTR1 0-140C vs 0-140T -0.73 1.66  0.017735 0-140C vs 0-140T 0.6  NS 
IGF1R 0-140C vs 60-140T  
0.524 
 
1.44  
0.035098 0-140C vs 60-140T 1.7  0.0185 
STAT3 0-140C vs 60-140 T -0.616 1.53  0.015966 0-140C vs 60-140T 1.1 NS 
 
  
Supplementary Table S5. Differentially expressed fetal ovarian proteins identified in one or more periods of exposure to chemicals in sewage 
sludge fertilizer.   
Spot # Protein Name Gene 
Symbol 
Mr (Da) pI MOWSE 
score 
NCBI Accession 
Number  
(UniProt) 
Sequence 
Coverage 
(%) 
Significantly different 
spot volume vs 0-140C:  
(+) = increased,  
(-) = decreased  
Network
n
 
1326
s
 Aldo-keto reductase 
family 1, member B1 
(aldose reductase) 
AKR1B1 36296 5.76 163 P16116 
 
13 0-80T (+) 
30-110T (+) 
1 
1160 Serum Albumin  ALB 71186 5.88 908 AAI02743 
 
43 60-140T (+) 1 
1326
p
 Biliverdin reductase A BLVRA 33907 5.85 497 NP_001091040 33 0-80T (+) 
30-110T (+) 
1 
1346
s
 Biliverdin reductase A BLVRA 33907 5.85 244 NP_001091040 19 0-80T (-) 1 
750 Gelsolin GSN 80966 5.54 120 NP_001029799 
(Q3SX14) 
6 60-140T (-) 1 
1544
p
 Glutathione S-
transferase Mu 1 
GSTM1 25789 6.90 280 NP_787019 
 
26 60-140T (+) 1 
1544
s
 Glutathione S-
transferase mu 3 
(Brain)  
GSTM3 27174 6.83 233 NP_001040025 23 60-140T (+) 1 
1443
p
 High mobility group 
protein 1  
HMGB1 25019 5.75 222 AAA57042 9 0-80T (+) 
30-110T (+) 
60-140T (+) 
1 
942 Lamin – M/C LMNA 79805 7.70 434 CAA27173 
(P02545) 
14 0-140T (+) 
0-80T (+) 
30-110T (+) 
60-140T (+) 
1 
660 Lamin-A/C  LMNA 79805 7.70 396 CAA27173 
 
14 30-110T (+) 1 
945 Lamin – A/C LMNA 79805 7.70 335 CAA27173 12 0-140T (+) 
0-80T (+) 
30-110T (+) 
60-140T (+) 
1 
1022 Protein disulfide-
isomerase A3 
PDIA3 57379 6.23 1280 NP_001156517 
 
46 0-80T (+) 
30-110T (+) 
60-140T (+) 
1 
1044
s2
 Aldehyde (retinal) 
dehydrogenase 1 
family, member A2 
ALDH1A2 57158 5.79 112 BAA34785 
 
10 30-110T (+) 
60-140T (+) 
1 
1630 Transgelin TAGLN 22609 8.87 625 NP_001103604 64 30-110T (+) 1 
827 Serotransferrin TF 79870 6.75 767 Q29443 
 
24 30-110T (-) 
60-140T (-) 
1 
966  Protein-glutamine 
gamma-
glutamyltransferase 2  
TGM2 78261 5.14 71 NP_803473 6 (+)0-80T (+) 
30-110T (+) 
1 
1044
s1
 D-3-phosphoglycerate 
dehydrogenase  
PHGDH 57327 6.47 345 NP_001030189 10 30-110T (+) 
60-140T (+) 
2 
1767 Hemoglobin fetal 
subunit beta 
HBB 15978 6.59 1033 P02083 94 60-140T (-) 2 
1443
s
 Haloacid-dehalogenase-
like hydrolase domain-
containing protein 2  
HDHD2 26749 5.81 72 BAB22395 
Q3UGR5 
12 0-80T (+) 
30-110T (+) 
60-140T (+) 
2 
1201
p
 COP9 signalosome 
complex subunit 4 
COPS4 43454 5.57 335 AAD43021 29 30-110T (+) 
60-140T (+) 
2 
1201
s
 Selenophosphate 
synthetase 1 
SEPHS1 43396 5.64 134 NP_036379 
 
10 30-110T (+) 
60-140T (+) 
2 
1346
p
 Serine/threonine protein 
phosphatise  
PPP1CB 37962 5.84 559 BAC40733 
 
40 0-80T (-) 2 
970
p
 Acetyl-CoA synthetase 
family member 2, 
mitochondrial 
ACSF2 68955 7.88 158 NP_001071580 
 
6 60-140T (+) 2 
970
s
 Paraspeckle component 
1 
PSPC1 41884 5.93 60 BAA91924 
 
5 60-140T (+) 2 
1044
p
 Dihydropyrimidinase-
related protein 2  
DPYSL2 62638 5.95 618 NP_001069468 26 30-110T (+) 
60-140T (+) 
2 
544 Collagen alpha-2(VI) 
chain 
COL6A2 109736 5.85 149 AAH65509 4 30-110T (+) 2 
1263 Short/branched chain 
specific acyl-CoA 
dehydrogenase, 
mitochondrial 
ACADSB 47797 6.53 91 NP_001600 5 0-80T (-) 
60-140 (+) 
2 
1524 Protein gene product 
9.5 
UCHL1 20319 5.02 147 AAP07110 
(Q80XX5) 
22 0-80T (+) 
60-140T (+) 
2 
886 Stress-70 protein, 
mitochondrial 
HSPA9 74019 5.97 330 AAA67526 
 
12 60-140T (+) 2 
664 Methylenetetrahydrofol
ate dehydrogenase 
(NADP+ dependent) 1 
MTHFD1 101740 6.91 273 NP_001076946 
(A4FUD0) 
8 30-110T (+) 
60-140T(+) 
2 
Expression is relative to controls (0-140C). The accession number is derived from NCBI or UniProt.  
* next to the spot number depicts spots containing significant protein matches that cannot be discriminated 
p
 Primary identification 
s
 Secondary identification in same protein spot 
n
IPA network analysis identified two networks: Network 1, Free Radical Scavenging, Cancer, Organismal Injury and Abnormalities, score = 31, 
focus molecules = 13, other molecules in network: Ap1, caspase, Creb, ERK, ERK1/2, Focal adhesion kinase, Growth hormone, Histone h3, 
Histone h4, IgG, IL1, IL12 (complex), Jnk, NFkB (complex), P38 MAPK, p85 (pik3r), PDGF BB, PI3K (complex), Pkc(s), PLC, Tgf beta, 
Vegf; Network 2, Hereditary Disorder, Metabolic Disease, Amino Acid Metabolism, score =35, focus molecules = 142, other molecules in 
network: ACAD10, Akt, CEP89, COL6A5, DNAJB3, DNAJC16, DNAJC17, DNAJC22, DNAJC28, GRPEL2, Hba1/Hba2, Mapk, MTHFD2L, 
NUDT6, SLC22A17, SPRED3, UBC, USP35, USP40, USP27X, YIPF1. 
 Supplementary Table S6: Top molecular and cellular functions affected by sewage sludge 
exposure. 
 
Name p-value #Molecules 
Free Radical Scavenging  3.94E-03 - 4.91E-08 9 
Cell-To-Cell Signaling and Interaction  1.44E-02 - 7.90E-06 10 
Small Molecule Biochemistry  1.44E-02 - 9.99E-06 16 
Drug Metabolism  1.44E-02 - 3.38E-05 8 
Protein Synthesis  6.56E-03 - 3.38E-05 8 
 
 Supplementary Table S7. Predicted downstream effects of the transcripts and proteins altered in the day 60-140 exposure group compared 
with controls (Supplementary table 2 and Supplementary table 5). The Activation z-score predicts the activation state of the upstream regulator, 
using the gene expression patterns of the genes downstream of an upstream regulator. An absolute z-score of ≥ 2 is considered significant. 
Diseases or 
Functions  
Predicted 
Activation 
State 
Activation 
z-score Molecules # Molecules 
Migration of 
cells Decreased -3.158 
ACTA2, ALB, BHLHE40, CCL2, CD36, CD8A, CD9, CES1, CXCL5, CYP1B1, 
CYP21A2, DCLK1, DPT, DPYSL2, ESR1, FRMD6, GLIPR2, GSN, HMGB1, 
HNRNPA2B1, IGF1, LMNA, LOX, MYLK, NES, NEUROD1, NRP1, S100A4, 
SFRP4, TAC1 30 
Cell movement Decreased -3.101 
ACTA2, ALB, BHLHE40, CAV3, CCL2, CD36, CD8A, CD9, CES1, CNN1, 
CXCL5, CYP1B1, CYP21A2, DCLK1, DPT, DPYSL2, ESR1, FGL2, FRMD6, 
GLIPR2, GSN, HMGB1, HNRNPA2B1, IGF1, LMNA, LOX, MBP, MYLK, 
NES, NEUROD1, NRP1, PDIA3, S100A4, SFRP4, TAC1 35 
Microtubule 
dynamics Decreased -2.850 
ABLIM1, CAV3, CCL2, CD9, DCLK1, DPYSL2, ESR1, FARP1, GEM, GSN, 
GSTM1, HMGB1, IGF1, KLF9, LOX, MBP, NEUROD1, NRP1, PDIA3, 
PHGDH, S100A4, STMN2, STX2, TAC1, TTLL1, UCHL1 26 
Organization of 
cytoplasm Decreased -2.824 
ABLIM1, CAV3, CCL2, CD9, DCLK1, DES, DPYSL2, ESR1, FARP1, FIS1, 
GEM, GSN, GSTM1, HMGB1, IGF1, KLF9, LOX, MBP, MBTPS1, NEUROD1, 
NRP1, PDIA3, PHGDH, S100A4, STMN2, STX2, TAC1, TF, TTLL1, UCHL1 30 
Organization of 
cytoskeleton Decreased -2.824 
ABLIM1, CAV3, CCL2, CD9, DCLK1, DES, DPYSL2, ESR1, FARP1, GEM, 
GSN, GSTM1, HMGB1, IGF1, KLF9, LOX, MBP, NEUROD1, NRP1, PDIA3, 
PHGDH, S100A4, STMN2, STX2, TAC1, TF, TTLL1, UCHL1 28 
Development of 
cardiovascular 
system Decreased -2.543 
ALDH1A2, AP1S2, CCL2, CD36, CD9, CXCL5, CYP1B1, ESR1, FGF18, GEM, 
GSN, GSTM1, HMGB1, IGF1, LOX, MTHFD1, NRP1, RBP4, S100A4, SOX4, 
SRGN, TAC1, TF 23 
Angiogenesis Decreased -2.543 
ALDH1A2, AP1S2, CCL2, CD36, CD9, CXCL5, CYP1B1, ESR1, FGF18, GEM, 
GSN, GSTM1, HMGB1, IGF1, LOX, NRP1, S100A4, SRGN, TAC1, TF 20 
Formation of 
cellular 
protrusions Decreased -2.495 
ABLIM1, CCL2, CD9, DCLK1, DPYSL2, FARP1, GEM, GSN, HMGB1, IGF1, 
KLF9, LOX, MBP, NEUROD1, NRP1, PDIA3, PHGDH, S100A4, STX2, TAC1, 
TTLL1, UCHL1 22 
Invasion of 
tumor cell lines Decreased -2.479 
ABLIM1, ACTA2, CCL2, CD9, CXCL5, CYP1B1, DPYSL2, ESR1, HMGB1, 
HNRNPA2B1, IGF1, LOX, NES, NRP1, S100A4, SOX4, UBD 17 
Advanced 
malignant tumor Decreased -2.439 
ABLIM1, ACTA2, ALDH1A2, CCL2, CD36, CD9, CNN1, CXCL5, CYP1B1, 
DPYSL2, ESR1, FGF18, GSTM3, HMGB1, IGF1, KIF20A, LGALS2, LOX, 
NES, NEUROD1, NRP1, PARP2, S100A4, STMN2, STX2, TXNIP, UBD 27 
Metastasis Decreased -2.439 
ABLIM1, ACTA2, CCL2, CD36, CD9, CNN1, CXCL5, CYP1B1, DPYSL2, 
ESR1, GSTM3, HMGB1, IGF1, KIF20A, LGALS2, LOX, NES, NEUROD1, 
NRP1, PARP2, S100A4, STMN2, STX2, TXNIP, UBD 25 
Migration of 
tumor cell lines Decreased -2.438 
ACTA2, CCL2, CD36, CD9, CXCL5, DPYSL2, ESR1, HNRNPA2B1, IGF1, 
LOX, NES, NRP1, S100A4, SFRP4, TAC1 15 
Vasculogenesis Decreased -2.417 
ALDH1A2, AP1S2, CCL2, CD36, CD9, CYP1B1, ESR1, GEM, GSN, GSTM1, 
HMGB1, IGF1, LOX, NRP1, S100A4, TAC1, TF 17 
Production of 
reactive oxygen 
species Decreased -2.306 CD36, GSN, HBB, HMGB1, HSPA9, IGF1, MYLK, TAC1, TXNIP 9 
Cell movement 
of tumor cell 
lines Decreased -2.260 
ACTA2, CCL2, CD36, CD9, CNN1, CXCL5, DPYSL2, ESR1, HNRNPA2B1, 
IGF1, LOX, NES, NEUROD1, NRP1, S100A4, SFRP4, TAC1 17 
Cell viability of 
tumor cell lines Decreased -2.219 
ABCG2, ALB, BHLHE40, CCL2, FKBP5, GSTM1, HBB, HMGB1, IGF1, 
NEUROD1, NRP1, POMP, PPP2R2B, S100A4 14 
Sprouting Decreased -2.183 
CCL2, DPYSL2, FARP1, GEM, HMGB1, IGF1, KLF9, NEUROD1, NRP1, 
PDIA3 10 
Cell viability Decreased -2.151 
ABCG2, ALB, BHLHE40, CCL2, CD8A, CD9, ESR1, FGF18, FKBP5, GSTM1, 
HBB, HMGB1, IGF1, LMNA, MBP, NEUROD1, NRP1, PDIA3, POMP, 
PPP2R2B, S100A4, TXNIP, UCHL1 23 
Branching of 
cells Decreased -2.143 
CCL2, DPYSL2, FARP1, GEM, HMGB1, IGF1, KLF9, NEUROD1, NRP1, 
PDIA3, STX2 11 
Quantity of 
metal Decreased -2.111 CCL2, CD8A, ESR1, GSN, IGF1, S100A4, SLC30A1, TAC1, TF, TXNIP 10 
Stimulation of 
cells Decreased -2.048 CCL2, CD8A, CXCL5, HMGB1, IGF1, MBP, NEUROD1, S100A4, TAC1 9 
Metastasis of Decreased -2.023 ABLIM1, CCL2, CNN1, CXCL5, IGF1, LOX, NEUROD1, S100A4, STX2, 11 
cells TXNIP, UBD 
Formation of 
plasma 
membrane 
projections Decreased -2.014 
DCLK1, DPYSL2, FARP1, GEM, HMGB1, IGF1, KLF9, LOX, MBP, 
NEUROD1, NRP1, PDIA3, PHGDH, TAC1, UCHL1 15 
Concentration of 
cholesterol Increased 2.141 CAV3, CD36, CES1, ESR1, LPL, MBTPS1, TXNIP 7 
Concentration of 
Triacylglycerol Increased 2.372 BHLHE40, CAV3, CD36, CES1, IGF1, LMNA, LPL, TXNIP 8 
Supplementary Table S8: Quantitative PCR Probes and Primer sequences. 
Target Primer sequence GenBank accession 
number 
GAPDH F: GGTTCACGCCCATCACA NM_001190390 
 R: ACTACCATGGAGAAGGCTGG 
PR: AGAGGGTCATCATCTCTGCACCTTCT 
HPRT F: GAACGGCTGGCTCGAG EE751310 
R: CCAACAGGTCGGCAAAG 
PR: AATGTGATGGCCACCCATCTCCT 
YWHAZ F: GGAGCCCGTAGGTCATCTTG AY970970 
R: CTCGAGCCATCTGCTGTTTTT  
PR: CAGCACCTTCCGTCTTTTGCTCAATA 
CTGGAGA 
AGTR1 F: CCAATTTCCAAAGGGCAGCAA AJ874684 
 R: GCTTAGCGAGTCTTTGTATGAAATGT  
PR: CTGTGGCCCACGTGTACCTGCTACTG  
IGF1R 
 
F: CAACCCAGGGAACTACACAG NM_001040479.1 
 R: ATATGTCGTCTTGGCCTGAA 
PR: CTCTCTCTGGGAATGGGTCATGGAC 
AGT F: TCCCACGCTCACTAGACTTG AF035417.1 
R: TTTCCTTGGAAGTGGACGTA 
PR: CCAAATCTCGCTGCTGAGAAGATCA 
STAT3 F: GCTGGAGCAGAAATCGTAAA AF257464.1 
R: CTTTAAGGGAGGGTCTCAGC 
PR: TCCGTGGCTCTTAGGTCATGTGAG 
IGHA2 F: AACCCACCCACGTGAACGT 
 
AF024645 
R: GGCGAGCGTGGAGTTTATTC  
 
PR: CTACTGAGTGCCCCCACCCCCA 
 
CALR F: GCTGTTTCCAGCTGGTTTGG CD288071 
R: CAGCACATTCTTGCCCTTGT 
PR: CCAGACATCTGTGGACCCGGCAC 
PTGFRN F: TGAGCGCAGACATGTTTACCA CU653858 
R: ACACTCGATTGTTCCATCAGAAAG 
PR: CACACGGCTCTTCTTCCCACGGC 
MHC 
CLASS I 
(HLA-B) 
F: AGGAGACGCAGGGAACTAAGG AJ874684 
R: GTAGCCGCGCAGGTTGT 
PR:CACTGCACTGACTTTCCGAGCGAACT 
RN28S1 F: TGGTTCCCTCCGAAGTTTCC CF118064 
R: CTAATCATTCGCTTTACCGGATAAA 
PR: CAGGATAGCTGGCGCTCTCGCAAC 
 
 
 
